<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="shortcut icon" href="https://www.biorxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/biorxiv/early/2018/04/11/201525.atom" />
<meta name="HW.pisa" content="biorxiv;201525v2" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="IFITM proteins inhibit HIV-1 protein synthesis" />
<meta name="DC.Identifier" content="10.1101/201525" />
<meta name="DC.Date" content="2018-04-11" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory" />
<meta name="DC.Rights" content="© 2018, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission." />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="Interferon induced transmembrane proteins (IFITMs) inhibit the cellular entry of a broad range of viruses, but it has been suspected that for HIV-1 IFITMs may also inhibit a post-integration replicative step. We show that IFITM expression reduces HIV-1 viral protein synthesis by preferentially excluding viral mRNA transcripts from translation and thereby restricts viral production. Codon-optimization of proviral DNA rescues viral translation, implying that IFITM-mediated restriction requires recognition of viral RNA elements. In addition, we find that expression of the viral accessory protein Nef can help overcome the IFITM-mediated inhibition of virus production. Our studies identify a novel role for IFITMs in inhibiting HIV replication at the level of translation, but show that the effects can be overcome by the lentiviral protein Nef." />
<meta name="DC.Contributor" content="Wing-Yiu Jason Lee" />
<meta name="DC.Contributor" content="Chen Liang" />
<meta name="DC.Contributor" content="Richard D Sloan" />
<meta name="article:published_time" content="2018-04-11" />
<meta name="article:section" content="New Results" />
<meta name="citation_title" content="IFITM proteins inhibit HIV-1 protein synthesis" />
<meta name="citation_abstract" lang="en" content="&lt;h3&gt;Abstract&lt;/h3&gt;
&lt;p&gt;Interferon induced transmembrane proteins (IFITMs) inhibit the cellular entry of a broad range of viruses, but it has been suspected that for HIV-1 IFITMs may also inhibit a post-integration replicative step. We show that IFITM expression reduces HIV-1 viral protein synthesis by preferentially excluding viral mRNA transcripts from translation and thereby restricts viral production. Codon-optimization of proviral DNA rescues viral translation, implying that IFITM-mediated restriction requires recognition of viral RNA elements. In addition, we find that expression of the viral accessory protein Nef can help overcome the IFITM-mediated inhibition of virus production. Our studies identify a novel role for IFITMs in inhibiting HIV replication at the level of translation, but show that the effects can be overcome by the lentiviral protein Nef.&lt;/p&gt;" />
<meta name="citation_journal_title" content="bioRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory" />
<meta name="citation_publication_date" content="2018/01/01" />
<meta name="citation_mjid" content="biorxiv;201525v2" />
<meta name="citation_id" content="201525v2" />
<meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/201525v2" />
<meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/201525v2.abstract" />
<meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/201525v2.full" />
<meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525.full.pdf" />
<meta name="citation_doi" content="10.1101/201525" />
<meta name="citation_num_pages" content="39" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_section" content="New Results" />
<meta name="citation_firstpage" content="201525" />
<meta name="citation_author" content="Wing-Yiu Jason Lee" />
<meta name="citation_author_institution" content="Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London" />
<meta name="citation_author_orcid" content="http://orcid.org/0000-0002-8524-3874" />
<meta name="citation_author" content="Chen Liang" />
<meta name="citation_author_institution" content="McGill University AIDS Centre, Lady Davis Institute" />
<meta name="citation_author" content="Richard D Sloan" />
<meta name="citation_author_institution" content="Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London" />
<meta name="citation_author_institution" content="Division of Infection and Pathway Medicine, School of Biomedical Sciences, University of Edinburgh" />
<meta name="citation_author_institution" content="ZJU-UoE Institute, Zhejiang University" />
<meta name="citation_reference" content="Malim, M. H. &amp; Bieniasz, P. D. HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect Med 2, a006940 (2012)." />
<meta name="citation_reference" content="Simon, V., Bloch, N. &amp; Landau, N. R. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat. Immunol. 16, 546–553 (2015)." />
<meta name="citation_reference" content="Kluge, S. F., Sauter, D. &amp; Kirchhoff, F. SnapShot: Antiviral Restriction Factors. Cell 163, 774–774.e1 (2015)." />
<meta name="citation_reference" content="Liu, L. et al. A whole genome screen for HIV restriction factors. Retrovirology 8, 94 (2011)." />
<meta name="citation_reference" content="Kane, M. et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502, 563–566 (2013)." />
<meta name="citation_reference" content="Goujon, C. et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559–562 (2013)." />
<meta name="citation_reference" content="Rosa, A. et al. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526, 212–217 (2015)." />
<meta name="citation_reference" content="Usami, Y., Wu, Y. &amp; Göttlinger, H. G. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526, 218–223 (2015)." />
<meta name="citation_reference" content="Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243–1254 (2009)." />
<meta name="citation_reference" content="Lu, J. et al. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85, 2126–2137 (2011)." />
<meta name="citation_reference" content="Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481–485 (2011)." />
<meta name="citation_reference" content="Wilson, S. J. et al. Inhibition of HIV-1 particle assembly by 2’,3“-cyclic-nucleotide 3”-phosphodiesterase. Cell Host Microbe 12, 585–597 (2012)." />
<meta name="citation_reference" content="Bailey, C. C., Zhong, G., Huang, I.-C. &amp; Farzan, M. IFITM-Family Proteins: The Cell’s First Line of Antiviral Defense. Annual Review of Virology 1, 261–283 (2014)." />
<meta name="citation_reference" content="Compton, A. A. et al. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread. Cell Host Microbe 16, 736–747 (2014)." />
<meta name="citation_reference" content="Tartour, K. et al. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology 11, 103 (2014)." />
<meta name="citation_reference" content="Tartour, K. et al. Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs. PLoS Pathog 13, e1006610 (2017)." />
<meta name="citation_reference" content="Amini-Bavil-Olyaee, S. et al. The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry. Cell Host Microbe 13, 452–464 (2013)." />
<meta name="citation_reference" content="Yu, J. et al. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Cell Rep 13, 145–156 (2015)." />
<meta name="citation_reference" content="Huang, I.-C. et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7, e1001258 (2011)." />
<meta name="citation_reference" content="Wilkins, C. et al. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57, 461–469 (2013)." />
<meta name="citation_reference" content="Savidis, G. et al. The IFITMs Inhibit Zika Virus Replication. Cell Rep 15, 2323–2330 (2016)." />
<meta name="citation_reference" content="Wang, Y. et al. The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity. J. Virol. 91, e02441–16 (2017)." />
<meta name="citation_reference" content="Kane, M. et al. Identification of Interferon-Stimulated Genes with Antiretroviral Activity. Cell Host Microbe 20, 392–405 (2016)." />
<meta name="citation_reference" content="Compton, A. A. et al. Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity. EMBO Rep. e201642771–15 (2016). doi:10.15252/embr.201642771" />
<meta name="citation_reference" content="Ding, S., Pan, Q., Liu, S.-L. &amp; Liang, C. HIV-1 mutates to evade IFITM1 restriction. Virology 454–455, 11–24 (2014)." />
<meta name="citation_reference" content="Chutiwitoonchai, N. et al. Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect. 15, 280–290 (2013)." />
<meta name="citation_reference" content="Qian, J. et al. Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins. Virology 474, 10–18 (2015)." />
<meta name="citation_reference" content="Foster, T. L. et al. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction. Cell Host Microbe 1–15 (2016). doi:10.1016/j.chom.2016.08.006" />
<meta name="citation_reference" content="Maréchal, V., Clavel, F., Heard, J. M. &amp; Schwartz, O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72, 2208–2212 (1998)." />
<meta name="citation_reference" content="Sloan, R. D. et al. Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis. J. Virol. 87, 8110–8123 (2013)." />
<meta name="citation_reference" content="Jolly, C., Booth, N. J. &amp; Neil, S. J. D. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J. Virol. 84, 12185–12199 (2010)." />
<meta name="citation_reference" content="la Vega, de, M. et al. Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion. Retrovirology 8, 99 (2011)." />
<meta name="citation_reference" content="Ikeda, Y. et al. Continuous high-titer HIV-1 vector production. Nat. Biotechnol. 21, 569–572 (2003)." />
<meta name="citation_reference" content="Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M. &amp; Mitrophanous, K. A. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74, 4839–4852 (2000)." />
<meta name="citation_reference" content="Kutluay, S. B. et al. Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis. Cell 159, 1096–1109 (2014)." />
<meta name="citation_reference" content="Pasquinelli, A. E. et al. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 16, 7500–7510 (1997)." />
<meta name="citation_reference" content="Zhang, F. et al. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6, 54–67 (2009)." />
<meta name="citation_reference" content="Matheson, N. J. et al. Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef. Cell Host Microbe 18, 409–423 (2015)." />
<meta name="citation_reference" content="Haller, C. et al. HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J. Virol. 88, 14241–14257 (2014)." />
<meta name="citation_reference" content="Fackler, O. T., d’Aloja, P., Baur, A. S., Federico, M. &amp; Peterlin, B. M. Nef from Human Immunodeficiency Virus Type 1F12 Inhibits Viral Production and Infectivity. J. Virol. 75, 6601–6608 (2001)." />
<meta name="citation_reference" content="Collette, Y. &amp; Olive, D. The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle. Virology 265, 173–177 (1999)." />
<meta name="citation_reference" content="Gummuluru, S., Kinsey, C. M. &amp; Emerman, M. An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus. J. Virol. 74, 10882–10891 (2000)." />
<meta name="citation_reference" content="Schindler, M. et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125, 1055–1067 (2006)." />
<meta name="citation_reference" content="Lim, E. S., Wu, L. I., Malik, H. S. &amp; Emerman, M. The function and evolution of the restriction factor Viperin in primates was not driven by lentiviruses. Retrovirology 9, 55 (2012)." />
<meta name="citation_reference" content="Yount, J. S., Karssemeijer, R. A. &amp; Hang, H. C. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 287, 19631–19641 (2012)." />
<meta name="citation_reference" content="Jia, R. et al. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J. Virol. 86, 13697–13707 (2012)." />
<meta name="citation_reference" content="Jia, R. et al. The C-Terminal Sequence of IFITM1 Regulates Its Anti-HIV-1 Activity. PLoS ONE 10, e0118794 (2015)." />
<meta name="citation_reference" content="Hach, J. C., McMichael, T., Chesarino, N. M. &amp; Yount, J. S. Palmitoylation on conserved and non-conserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity. J. Virol. (2013). doi:10.1128/JVI.00621-13" />
<meta name="citation_reference" content="Coller, J. &amp; Parker, R. General Translational Repression by Activators of mRNA Decapping. Cell 122, 875–886 (2005)." />
<meta name="citation_reference" content="Gao, G., Guo, X. &amp; Goff, S. P. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297, 1703–1706 (2002)." />
<meta name="citation_reference" content="Zhu, Y., Wang, X., Goff, S. P. &amp; Gao, G. Translational repression precedes and is required for ZAP-mediated mRNA decay. EMBO J. 31, 4236–4246 (2012)." />
<meta name="citation_reference" content="Shin, Y. C., Bischof, G. F., Lauer, W. A. &amp; Desrosiers, R. C. Importance of codon usage for the temporal regulation of viral gene expression. Proc. Natl. Acad. Sci. U.S.A. 112, 14030–14035 (2015)." />
<meta name="citation_reference" content="Chang, D. D. &amp; Sharp, P. A. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59, 789–795 (1989)." />
<meta name="citation_reference" content="Grantham, P. &amp; Perrin, P. AIDS virus and HTLV-I differ in codon choices. Nature 319, 727–728 (1986)." />
<meta name="citation_reference" content="Kypr, J. &amp; Mrázek, J. Unusual codon usage of HIV. Nature 327, 20–20 (1987)." />
<meta name="citation_reference" content="Takata, M. A. et al. CG dinucleotide suppression enables antiviral defence targeting non-self RNA. Nature 550, 124–127 (2017)." />
<meta name="citation_reference" content="Reid, D. W. &amp; Nicchitta, C. V. Diversity and selectivity in mRNA translation on the endoplasmic reticulum. Nature Publishing Group 16, 221–231 (2015)." />
<meta name="citation_reference" content="Li, K. et al. IFITM Proteins Restrict Viral Membrane Hemifusion. PLoS Pathog 9, e1003124 (2013)." />
<meta name="citation_reference" content="Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. &amp; Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397–401 (1998)." />
<meta name="citation_reference" content="Schwartz, O., Maréchal, V., Le Gall, S., Lemonnier, F. &amp; Heard, J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338–342 (1996)." />
<meta name="citation_reference" content="Vendrame, D., Sourisseau, M., Perrin, V., Schwartz, O. &amp; Mammano, F. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer. J. Virol. 83, 10527–10537 (2009)." />
<meta name="citation_reference" content="Jolly, C. Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors. Virology 411, 251–259 (2011)." />
<meta name="citation_reference" content="Kuhl, B. D. et al. Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology 7, 115 (2010)." />
<meta name="citation_reference" content="Casartelli, N. et al. Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog 6, e1000955 (2010)." />
<meta name="citation_reference" content="Park, H. et al. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc Natl Acad Sci USA 91, 4713–4717 (1994)." />
<meta name="citation_reference" content="Li, M. et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 491, 125–128 (2012)." />
<meta name="citation_reference" content="Goodier, J. L., Pereira, G. C., Cheung, L. E., Rose, R. J. &amp; Kazazian, H. H. The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition. PLoS Genet. 11, e1005252–32 (2015)." />
<meta name="citation_reference" content="Schmitz, C. et al. Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J. Virol. 78, 2006–2016 (2004)." />
<meta name="citation_reference" content="Ogunkolade, B. W. et al. BORIS/CTCFL is an RNA-binding protein that associates with polysomes. BMC Cell Biol. 14, 52 (2013)." />
<meta name="citation_reference" content="Yamamoto, N. et al. Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes 32, 105–113 (2006)." />
<meta name="citation_reference" content="Sloan, R. D. et al. Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef. J. Virol. 85, 2828–2836 (2011)." />
<meta name="citation_reference" content="Wu, Y. &amp; Marsh, J. W. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293, 1503–1506 (2001)." />
<meta name="twitter:title" content="IFITM proteins inhibit HIV-1 protein synthesis" />
<meta name="twitter:site" content="@biorxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="twitter:description" content="Interferon induced transmembrane proteins (IFITMs) inhibit the cellular entry of a broad range of viruses, but it has been suspected that for HIV-1 IFITMs may also inhibit a post-integration replicative step. We show that IFITM expression reduces HIV-1 viral protein synthesis by preferentially excluding viral mRNA transcripts from translation and thereby restricts viral production. Codon-optimization of proviral DNA rescues viral translation, implying that IFITM-mediated restriction requires recognition of viral RNA elements. In addition, we find that expression of the viral accessory protein Nef can help overcome the IFITM-mediated inhibition of virus production. Our studies identify a novel role for IFITMs in inhibiting HIV replication at the level of translation, but show that the effects can be overcome by the lentiviral protein Nef." />
<meta name="og-title" property="og:title" content="IFITM proteins inhibit HIV-1 protein synthesis" />
<meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/201525v2" />
<meta name="og-site-name" property="og:site_name" content="bioRxiv" />
<meta name="og-description" property="og:description" content="Interferon induced transmembrane proteins (IFITMs) inhibit the cellular entry of a broad range of viruses, but it has been suspected that for HIV-1 IFITMs may also inhibit a post-integration replicative step. We show that IFITM expression reduces HIV-1 viral protein synthesis by preferentially excluding viral mRNA transcripts from translation and thereby restricts viral production. Codon-optimization of proviral DNA rescues viral translation, implying that IFITM-mediated restriction requires recognition of viral RNA elements. In addition, we find that expression of the viral accessory protein Nef can help overcome the IFITM-mediated inhibition of virus production. Our studies identify a novel role for IFITMs in inhibiting HIV replication at the level of translation, but show that the effects can be overcome by the lentiviral protein Nef." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="citation_date" content="2018-04-11" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/201525v2.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/201525v2.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/201525v2.ppt" />
<meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.biorxiv.org/content/10.1101/201525v2" />
<link rel="shortlink" href="https://www.biorxiv.org/node/92005" />
    <title>IFITM proteins inhibit HIV-1 protein synthesis | bioRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__jMRAK66KMC1e4TQlwUNn3KiWVDC5AjueUAYEm1xBY_U__KSUjdT4jdcJ4qJz6fKY1K9WkYh1a5EcaWZxt_-zbTis__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?q8qadd" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__qlYh2rDEXmsOlJKnxoaEiN2PoZU7YzDXSSTk6K1VAQE__XkaAZGAgxyDmOmv0mrGL0sA-jzEgAbgA12amvVPlIf0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__vup9YXfxWOBOGbthJCUtxdPS6xRY2OQ_vXqbojfxPAk__ziC21uj-cnpEf3LG0kjRMEQHSEtjX5ljVuosklz2DZ4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__B6tGdsQSt1vT8d8j-19-oS4FKJe83RrSNBkjPs9jfos__6VkE5WcQmmQpSVTQx-xS2-zn_nlwFlDm-EN1HLJNjrA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__78WRxe8YsWkYp6RcQ_VwTjFG__x9mi_NTPqoxAwFUsA__F3sVKlGyHKCaAPI_WdiHD7l_-05B6b9bLdUwzi1me90__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__dAeSAHswzRXxn-2n4D6zNPmcZDmwaqqLzE-2ab_8jKw__f_9pwrTE8mmshoJRfurwkQ36QonD_Jiwbop2sscnkrE__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/all/libraries/modernizr/modernizr.min.js?q8qadd"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__yOhrJUBmMpN-jsuQlJYmS8ovkQU6I6KInr295HrSTb0__c--zHhbuOWmkdWkJYXiNWDmkpDRPesmbBjGlQcyqBOY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js___KyvuEvfmewWxdOLBXTYsSUo8Pfm_DijV6fWtGvSL_k__HSKkTgIr7nDcdvQYewipf6v4ak6ZLUOQkwPj44wKouA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__OGPr3wJNGw2BAY3Tj6TjIBwKmjQh5i-7muOaPrr0MFA__fCWiU_pDm6xztXUSccH7zrf5422-kgOkuLdWyafrH_0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__hqoKSXYZqkcZkXP--ltzsy0Y3txW5TJBw6HT1khr30Y__6_HqNYoBVMxlkWZwdscqCLCtCxpOhl9_rIOpTDdaI0k__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__lrItkPGmrIuH-E_sdUWEK2i9eTqLar16BAHVxNTWqrc__FhtnljBrjuzYWWrT_f4OYV4jtMBituhMpusb3h0m0rY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-45638026-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__1PtAOZ8x7l6QAi8D7X6Kj_Y7HcUOFzvWRvvYHUcCT98__U8IB92u_CnnGwJ-X_xaUa9lzsC8OzUfN0WkK2JQfirg__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"trK8nwsXx9fN2fJp52r_jEgVr30hsyWVIBHra4VgxKQ","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"modules\/forum\/forum.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/default\/modules\/biorxiv\/css\/biorxiv.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_collection\/css\/highwire_subject_collection.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire.highwire-list-expand.css":1,"public:\/\/ctools\/css\/bab59090150caf0c64e27afa1b36eef1.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"0":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/default\/modules\/jnl_biorxiv_styles\/css\/biorxiv-styles.css.less":1,"https:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"http:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/adv-search-collection-toggle.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/biorxiv-scripts.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/default\/modules\/contrib\/disqus\/disqus.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/twitter_button.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/facebook_like.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/google_plus_one.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.highwire-list-expand.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"92005","apath":"\/biorxiv\/early\/2018\/04\/11\/201525.atom","pisa":"biorxiv;201525v2","markup":[{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;201525\/DC1"},{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;201525\/DC1"},{"requested":"full-text","variant":"full-text","view":"full","pisa":"biorxiv;201525v2"},{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;201525\/DC1"},{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;201525\/DC1"}],"processed":["highwire_math"],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"biorxivstage","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/201525v2","title":"IFITM proteins inhibit HIV-1 protein synthesis","identifier":"node\/92005"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022PppSVsY4gO4bCtfRKDVgF4x1SDMfT9moa+aTSLtz2nalwcSOpFJFRkEhlp6zTwtrl4L6LbVcu+EOPYLEY2AjmIyobyduWLEKTBVN6I3dGa8dEIYL3hfeZpadj+Q+Sc6HgBAYF3K0dcu8yLNRhBiv+gnUnC75u+XSQZz6uFULvNMB+9XylY4KNUBLMWYDGefwhCiqThf7skzW9rV4u5CRnjkF0PuH5IoZvKL7Ay7PV6TGSzL13S+V9WojYKNqQRyddl6OEekqrGIJ7N2mF0cc9Pz+6fC+a5xkwAPdqhshysM4ciAbf3MEg9ykX9Uf5\\\\\\\/f8H3fWZkG+gZhBB4RIdMhh+7qPpUMMIdB94aTZrAU9R8D6OBG521zEtaCGGcUNZRy5tDk08dFIGpRqWNz91ondXS9wgR7BTs1LqYOxLA4boYZCfglhhsyVNdXZ32K0tGYhA2nFJQ+1bmkLfaL5\\\\\\\/5NV2fPOWG7AIxT4+dpRas5xozFXhxurJymQEJkyOwqVfxxfPXwNTkAVrp30p3x0XBifn7fodEr5XMgJE539kC1AQ7n6XSJdr2557Q\\\\\\\/E8AHHLAS3rhoPdwMyeJxbTnTx65Tt5P2Dkz4zA7ea\\\\\\\/CVqHd8HdC\\\\\\\/B1JSL2imA4IWXtM4nYX\\\\\\\/gldNmO3VAUNlOfTSODQGvC6lMv3eSOua+5vlOptqE6Wc+WrHLwmwLt7qShf11WmR7Bacci98Wmx+e4JDdewMHAyQdSppbWyW\\\\\\\/8FyuCmluowsdDfCJiedxy9xkeQZXQon9g4P75IZalXH3XgXiFSiClGdqtZzevCRRJ5t4grZPNNS\\\\\\\/BLolz18cf7P9FyQOqkxULxSa0uqd+GqF3tFNEay+hfm8nbTg1ILQU3cHBlBCNnnIEeZNcIf2smEcIno+ppNzLxbft8LeBFLoRa\\\\\\\/t+B3jvb1k1GAdOhLpQ9Mcettt0lemhkrbYMTjgsSVu5NgrtBGsVeh6TtlBF\\\\\\\/p9ZpzOFlfoFYPAz2lCvQbMHQUgXMjj+w6zUSLVmjJZaL4QxtB+46gnEzbFtQ2uAUejVJpIdy4Q1TsZ4HSZBYaOmIds81kDPReul0ly9w+oHPIVI7yrFCUOs4yzi14lhdIUcB6tgU4N03b4RvKeGT54PHrlKuxhn132kYEuNCTE10keW5u9lXgyXeiZwJMC7+Mh501uqW5+ujQ85\\\\\\\/PEZsbRR+wW+2GJdYelXS2DFARkKNsACSh\\\\\\\/iP5YK4\\\\\\\/0yRrYptTICd1fdKQYP+V+Yq7ZspEAe\\\\\\\/tf3xFSM1CaLLEgwscFTEYScbkxugNng23deUaGRsTKZraRiWmz52rmmC8bjfAqTqfjtawW5I=\\\u0022,\\\u0022iv\\\u0022:\\\u0022\\\\\\\/VCSkCV8qcKJEYWjewrR8w==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u0022d246f7ad979fc78b77b8e9012bb6af247bf6aebc07002afe2d5dc050ebc18cca\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/201525v2.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.biorxiv.org\/sites\/default\/files\/bioRxiv_article.jpg"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"biorxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-92005 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-M677548" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="bioRxiv" src="https://www.biorxiv.org/sites/default/files/bioRxiv_article.jpg" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/about-biorxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/201525v2.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-bp5AaOtXtjAN4t6xadAs7C1bUBn30Aa_686_IvlyZ8M" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="92005" id="node92005" data-pisa="biorxiv;201525v2" data-pisa-master="biorxiv;201525" data-apath="/biorxiv/early/2018/04/11/201525.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-top clearfix has-author-tooltip" >

      <span class="biorxiv-article-type">
        New Results    </span>
  
        <h1 class="highwire-cite-title" id="page-title">IFITM proteins inhibit HIV-1 protein synthesis</h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first hw-author-orcid-logo-wrapper" data-delta="0"><a href="http://orcid.org/0000-0002-8524-3874" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon"><i class="hw-icon-orcid hw-icon-color-orcid"></i> <span class="title element-invisible">View ORCID Profile</span></a><span class="nlm-given-names">Wing-Yiu Jason</span> <span class="nlm-surname">Lee</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Chen</span> <span class="nlm-surname">Liang</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Richard D</span> <span class="nlm-surname">Sloan</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/201525 </span></div>
  
  
  </div>
<div id="hw-article-author-popups-node92005" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Wing-Yiu Jason Lee </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London</span>, London E1 2AT, <span class='nlm-country'>United Kingdom</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Wing-Yiu%2BJason%2BLee%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Lee%20WJ&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3AWing-Yiu%2BJason%2BLee%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-orcid-link last"><a href="http://orcid.org/0000-0002-8524-3874" target="_blank" class="" data-icon-position="" data-hide-link-title="0">ORCID record for Wing-Yiu Jason Lee</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Chen Liang </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>McGill University AIDS Centre, Lady Davis Institute</span>, Montreal, Quebec H3T 1E2, <span class='nlm-country'>Canada</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Chen%2BLiang%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Liang%20C&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AChen%2BLiang%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Richard D Sloan </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London</span>, London E1 2AT, <span class='nlm-country'>United Kingdom</span></div><div class='author-affiliation'><span class='nlm-sup'>3</span><span class='nlm-institution'>Division of Infection and Pathway Medicine, School of Biomedical Sciences, University of Edinburgh</span>, Edinburgh EH16 4SB, <span class='nlm-country'>United Kingdom</span></div><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>ZJU-UoE Institute, Zhejiang University</span>, Haining, Zhejiang 314400, P.R. <span class='nlm-country'>China</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Richard%2BD%2BSloan%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Sloan%20RD&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ARichard%2BD%2BSloan%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/201525v2" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:92005" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:92005/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/201525v2.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:92005" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:92005/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/201525v2.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:92005" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:92005/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/201525v2.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:92005" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:92005/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/201525v2.supplementary-material" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:92005" data-trigger="supplementary-material" data-url-enabled="1">Supplementary material</a><a href="/panels_ajax_tab/biorxiv_tab_data/node:92005/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/201525v2.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:92005" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:92005/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-article_tab_full_text"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">Abstract</h2><p id="p-3">Interferon induced transmembrane proteins (IFITMs) inhibit the cellular entry of a broad range of viruses, but it has been suspected that for HIV-1 IFITMs may also inhibit a post-integration replicative step. We show that IFITM expression reduces HIV-1 viral protein synthesis by preferentially excluding viral mRNA transcripts from translation and thereby restricts viral production. Codon-optimization of proviral DNA rescues viral translation, implying that IFITM-mediated restriction requires recognition of viral RNA elements. In addition, we find that expression of the viral accessory protein Nef can help overcome the IFITM-mediated inhibition of virus production. Our studies identify a novel role for IFITMs in inhibiting HIV replication at the level of translation, but show that the effects can be overcome by the lentiviral protein Nef.</p></div><div class="section" id="sec-1"><h2 class="">Background</h2><p id="p-4">Viruses must replicate in cells; the consequence of such dependence is susceptibility. Cells have thus evolved a series of antiviral factors that directly subvert viral replication. Recent work has revealed the striking scale of antiviral mechanisms employed by cells - almost every step of viral replication is apparently targeted by host encoded antiviral factors. For HIV the best defined examples are APOBEC3G/3F and SamHD1 that inhibit viral reverse transcription, TRIM5α that targets viral capsid uncoating, and tetherin that prevents viral egress (reviewed in <sup><a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>,<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a></sup>). However, genomic and proteomic screens can aid identification of further antiviral factors, and so there is an expanding list being described <sup><a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>,<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a></sup>. Such studies identified the MxB/Mx2 protein that targets HIV-1 replication around nuclear entry <sup><a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>,<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a></sup>, and the SERINC3 and SERINC5 proteins that target HIV-1 entry <sup><a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>,<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a></sup>.</p><p id="p-5">The interferon induced transmembrane proteins (IFITMs) have been similarly identified in multiple independent screens as antiviral factors <sup><a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>–<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a></sup>. Humans have three antiviral IFITMs - IFITM1, IFITM2 and IFITM3 (reviewed in <sup><a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a></sup>). IFITM expression inhibits viral entry into cells <sup><a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a></sup>, a phenotype that is enhanced by incorporation of IFITM proteins into viral particles <sup><a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>–<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a></sup>. Inhibition of viral entry is thought to occur via IFITM-mediated changes in the physical characteristics of the host cell membrane thereby inhibiting virus-cell membrane fusion <sup><a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a></sup>, though other inhibitory mechanisms affecting entry have been proposed <sup><a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a></sup>. By employing this generic inhibitory mechanism, IFITMs can then inhibit the entry of a broad range of viruses including influenza A virus, hepatitis C virus, Ebola virus, SARs coronavirus, Dengue virus, Zika virus, and HIV-1 <sup><a id="xref-ref-9-3" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>–<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a></sup>.</p><p id="p-6">Yet since the discovery of their antiviral effect upon HIV-1, it was immediately apparent that a viral replication step downstream of host genome integration might also be inhibited by IFITM proteins, as IFITM1 knockdown increased HIV-1 titres from infected CD4<sup>+</sup> T-cells <sup><a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a></sup>. In the same study, IFITM1 inhibited the replication of HIV-1 in T-cell culture despite the evidence that IFITM1 had no effect on viral replication steps from cell entry to host genome integration for the viral strain used. Other studies have also noted IFITM1-3 expression reduces viral particle production from cells <sup><a id="xref-ref-12-2" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14">14</a>–<a id="xref-ref-16-2" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>–<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a></sup>. When this occurs, IFITM expression is typically associated with reductions in HIV-1 Gag levels, implying a block in viral protein synthesis.</p><p id="p-7">Despite the frequency of these observations, there has been little to no attempt to explain them. Why viral production should be affected by IFITM expression is unclear. We therefore sought to investigate the potential block in protein synthesis induced by IFITMs and now show that IFITM expression leads to an inhibition of lentiviral production, which for HIV-1 occurs due to specific exclusion of viral mRNA from polysomes. Yet we also find that expression of the lentiviral accessory protein Nef can help relieve the inhibition in virus production, allowing HIV-1 to better replicate in the presence of IFITM proteins. Thus IFITM proteins are able to inhibit HIV-1 replication through three distinct processes - inhibition of viral entry, reduction of viral particle infectivity, and inhibition of viral protein synthesis.</p></div><div class="section" id="sec-2"><h2 class="">Results</h2><div id="sec-3" class="subsection"><h3>IFITMs inhibit HIV-1 production</h3><p id="p-8">We first wanted to confirm if IFITMs affect the production of HIV from virus producing cells as noted in previous reports <sup><a id="xref-ref-10-4" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-12-3" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-14-3" class="xref-bibr" href="#ref-14">14</a>–<a id="xref-ref-16-3" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22</a>–<a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a></sup>. We used a co-transfection scheme in which we co-transfected HEK293T cells with plasmids containing HIV-1 proviral DNAs together with expression vectors encoding human IFITM1-3, allowing the effects on virus production to be studied independently of effects of IFITM proteins on viral entry. The quantity of virus produced was then analyzed by supernatant p24 ELISA and reverse transcriptase activity assays. Increasing levels of IFITM expression decreased HIV-1 NL4-3 output by in a concentration-dependent manner consistent with loss of intracellular p55 and p24 levels (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1A, 1B</a>), with a similar decrease seen in supernatant when both p24 concentration (<a id="xref-fig-1-2" class="xref-fig" href="#F1">Figure 1C</a>) and reverse transcriptase activity (<a id="xref-fig-1-3" class="xref-fig" href="#F1">Figure 1D</a>) were measured. Notably, the expression of IFITM1 and IFITM2 reduced the HIV-1 output while the effect was weaker for IFITM3. We then studied the effect of IFITMs on other viral proteins, and found IFITM1 and IFITM2 expression led to a reduction in the levels of all HIV-1 NL4-3 proteins assayed in transfected cells (<a id="xref-fig-1-4" class="xref-fig" href="#F1">Figure 1E</a>). Similar to HIV-1 NL4-3, viral production from the HIV-1 plasmid proviral DNAs 89.6 and Indie-C1 was also reduced by IFITM expression (<a id="xref-fig-1-5" class="xref-fig" href="#F1">Figure 1C and D</a>).</p><p id="p-9">In addition to HIV-1, the expression of IFITMs also reduced the quantity of virus produced from cells transfected with plasmid proviral DNAs for HIV-2 and SIVs (Figure S1A and S1B). Of note, HIV-2<sub>ROD</sub> and SIV<sub>AGM</sub> appeared to be less susceptible to this IFITM-mediated effect compared to the HIV-1 viruses studied. We also found similar inhibitory effects upon HIV-1 with transfected African Green Monkey IFITM1 (Figure S1C).</p><div id="F1" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="IFITMs inhibit HIV viral output and viral protein production in transfected cells HEK293T cells were transfected with a titration of expression vectors for FLAG tagged IFITMs. (A) Levels of virus production were measured by p24 ELISA 48h post-transfection, and (B) cellular viral proteins and IFITMs were analyzed by immunoblotting. HEK293T cells were transfected with 0.5&#x3BC;g of FLAG-tagged IFITM expression vectors and 0.5&#x3BC;g of HIV-1 NL4-3 proviral DNA. Levels of virus production from indicated HIV-1 proviral DNAs were measured by (C) p24 ELISA and (D) reverse transcriptase (RT) activity assay and (E) immunoblotting of intracellular proteins 48h post-transfection. (F) Level of GFP expression in HEK293T cells co-transfected with 0.5&#x3BC;g CMV-driven GFP vector and 0.5&#x3BC;g IFITM-expression vectors or empty vectors measured by flow cytometry 48 hours post-transfection. (G) HIV-1 NL4-3 virus was produced from HEK293T cells transfected with vector or the indicated IFITMs in TZM-bl cells for 48 hours. Infectivity in TZM-bl cells was measured by luciferase activity assay 48 hours after infection with virus stock with equivalent p24 concentration. Data show mean + S.E.M. of more than 3 independent experiments. All differences were assessed with Student&#x2019;s t-test and * indicates p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1939130801" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;IFITMs inhibit HIV viral output and viral protein production in transfected cells&lt;/span&gt; HEK293T cells were transfected with a titration of expression vectors for FLAG tagged IFITMs. &lt;strong&gt;(A)&lt;/strong&gt; Levels of virus production were measured by p24 ELISA 48h post-transfection, and &lt;strong&gt;(B)&lt;/strong&gt; cellular viral proteins and IFITMs were analyzed by immunoblotting. HEK293T cells were transfected with 0.5&#x3BC;g of FLAG-tagged IFITM expression vectors and 0.5&#x3BC;g of HIV-1 NL4-3 proviral DNA. Levels of virus production from indicated HIV-1 proviral DNAs were measured by &lt;strong&gt;(C)&lt;/strong&gt; p24 ELISA and &lt;strong&gt;(D)&lt;/strong&gt; reverse transcriptase (RT) activity assay and &lt;strong&gt;(E)&lt;/strong&gt; immunoblotting of intracellular proteins 48h post-transfection. &lt;strong&gt;(F)&lt;/strong&gt; Level of GFP expression in HEK293T cells co-transfected with 0.5&#x3BC;g CMV-driven GFP vector and 0.5&#x3BC;g IFITM-expression vectors or empty vectors measured by flow cytometry 48 hours post-transfection. &lt;strong&gt;(G)&lt;/strong&gt; HIV-1 NL4-3 virus was produced from HEK293T cells transfected with vector or the indicated IFITMs in TZM-bl cells for 48 hours. Infectivity in TZM-bl cells was measured by luciferase activity assay 48 hours after infection with virus stock with equivalent p24 concentration. Data show mean + S.E.M. of more than 3 independent experiments. All differences were assessed with Student&#x2019;s t-test and * indicates p&lt;0.05.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F1.medium.gif" width="440" height="357"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 1." src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F1.medium.gif" width="440" height="357"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">Figure 1.</span> <span class="caption-title">IFITMs inhibit HIV viral output and viral protein production in transfected cells</span><p id="p-10" class="first-child">HEK293T cells were transfected with a titration of expression vectors for FLAG tagged IFITMs. <strong>(A)</strong> Levels of virus production were measured by p24 ELISA 48h post-transfection, and <strong>(B)</strong> cellular viral proteins and IFITMs were analyzed by immunoblotting.</p><p id="p-11">HEK293T cells were transfected with 0.5μg of FLAG-tagged IFITM expression vectors and 0.5μg of HIV-1 NL4-3 proviral DNA. Levels of virus production from indicated HIV-1 proviral DNAs were measured by <strong>(C)</strong> p24 ELISA and <strong>(D)</strong> reverse transcriptase (RT) activity assay and <strong>(E)</strong> immunoblotting of intracellular proteins 48h post-transfection. <strong>(F)</strong> Level of GFP expression in HEK293T cells co-transfected with 0.5μg CMV-driven GFP vector and 0.5μg IFITM-expression vectors or empty vectors measured by flow cytometry 48 hours post-transfection. <strong>(G)</strong> HIV-1 NL4-3 virus was produced from HEK293T cells transfected with vector or the indicated IFITMs in TZM-bl cells for 48 hours. Infectivity in TZM-bl cells was measured by luciferase activity assay 48 hours after infection with virus stock with equivalent p24 concentration. Data show mean + S.E.M. of more than 3 independent experiments. All differences were assessed with Student’s t-test and * indicates p&lt;0.05.</p><div class="sb-div caption-clear"></div></div></div><p id="p-12">We were concerned however that the loss of viral production we saw might be due to generic inhibition of protein production during IFITM expression, but detection of GFP from a transfected reporter plasmid was not significantly affected by IFITM expression (<a id="xref-fig-1-6" class="xref-fig" href="#F1">Figure 1F</a>). We also measured the infectivity of the virus produced from IFITM-expressing cells, in TZM-bl cells and showed that virus produced have lower infectivity (<a id="xref-fig-1-7" class="xref-fig" href="#F1">Figure 1G</a>), in agreement with previous results <sup><a id="xref-ref-14-4" class="xref-bibr" href="#ref-14">14</a>–<a id="xref-ref-16-4" class="xref-bibr" href="#ref-16">16</a></sup>.</p><p id="p-13">We noted that levels of IFITM proteins in transfected 293T cells were often higher than those seen in type-I interferon treated CD4+ T-cells and monocyte derived macrophages (MDMs) (Figure S2) and so we next investigated the influence of IFITM proteins in cells in which levels of expression could be inducibly expressed. While we also wanted to test if IFITMs inhibit viral production in infected cells rather than provirus transfected cells. As such we infected SupT1 cells expressing doxycycline inducible IFITM1-3 with wild type NL4-3 virus <sup><a id="xref-ref-10-5" class="xref-bibr" href="#ref-10">10</a></sup>. To avoid the well documented inhibition of virus entry by IFITMs playing a role in our experiments, after spinoculation, unbound virus was washed off and cells were resuspended in new medium containing doxycycline and the CXCR4 antagonist AMD3100 to induce IFITM expression only after virus entry and to limit viral replication to a single round respectively. Complete entry blockade was confirmed with pre-treatment of cells (Figure S2A). The quantity of wild type HIV-1 produced by IFITM-expressing T-cells was inhibited across a range of viral inputs and was paired with losses in all viral protein levels, but with p55 levels somewhat less affected (<a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2B</a>). Though collectively this indicates that IFITMs inhibit viral production independent of their effects on viral entry. Notably, the levels of doxycycline induced IFITM were similar to those found in type I interferon treated CD4+ T-cells and monocyte derived macrophages (Figure S2B, C and E).</p><div id="F2" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Inducible expression of IFITMs after viral entry inhibits HIV viral output and viral protein production in infected SupT1 cells (A) SupT1 cells were infected with the indicated dilutions of wild type HIV-1 NL4-3 inoculum and then treated with 1&#x3BC;g/ml doxycycline to induce IFITMs post-entry and 5&#x3BC;M AMD3100 to limit infection to a single cycle. At 72h post-infection levels of virus production were measured by p24 ELISA and differences assessed by Two-way ANOVA with Bonferroni&#x2019;s multiple comparison test. (B) Cellular viral proteins and IFITMs were analyzed by immunoblotting and (C) densitometry. Data show mean + S.E.M. of 3 independent experiments. Differences were assessed with Student&#x2019;s t-test and * indicates p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1939130801" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Inducible expression of IFITMs after viral entry inhibits HIV viral output and viral protein production in infected SupT1 cells&lt;/span&gt; &lt;strong&gt;(A)&lt;/strong&gt; SupT1 cells were infected with the indicated dilutions of wild type HIV-1 NL4-3 inoculum and then treated with 1&#x3BC;g/ml doxycycline to induce IFITMs post-entry and 5&#x3BC;M AMD3100 to limit infection to a single cycle. At 72h post-infection levels of virus production were measured by p24 ELISA and differences assessed by Two-way ANOVA with Bonferroni&#x2019;s multiple comparison test. &lt;strong&gt;(B)&lt;/strong&gt; Cellular viral proteins and IFITMs were analyzed by immunoblotting and &lt;strong&gt;(C)&lt;/strong&gt; densitometry. Data show mean + S.E.M. of 3 independent experiments. Differences were assessed with Student&#x2019;s t-test and * indicates p&lt;0.05.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F2.medium.gif" width="404" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 2." src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F2.medium.gif" width="404" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 2.</span> <span class="caption-title">Inducible expression of IFITMs after viral entry inhibits HIV viral output and viral protein production in infected SupT1 cells</span><p id="p-14" class="first-child"><strong>(A)</strong> SupT1 cells were infected with the indicated dilutions of wild type HIV-1 NL4-3 inoculum and then treated with 1μg/ml doxycycline to induce IFITMs post-entry and 5μM AMD3100 to limit infection to a single cycle. At 72h post-infection levels of virus production were measured by p24 ELISA and differences assessed by Two-way ANOVA with Bonferroni’s multiple comparison test. <strong>(B)</strong> Cellular viral proteins and IFITMs were analyzed by immunoblotting and <strong>(C)</strong> densitometry. Data show mean + S.E.M. of 3 independent experiments. Differences were assessed with Student’s t-test and * indicates p&lt;0.05.</p><div class="sb-div caption-clear"></div></div></div><p id="p-15">We next wished to investigate this effect using knockdown of endogenous IFITM levels to avoid overexpression artefact, and to assess the relative contribution of IFITMs towards inhibition of viral production that is observed with type I interferon (IFN) treatment. We therefore analyzed viral output from HIV-1 NL4-3 plasmid proviral DNA transfected and IFN-β treated TZM-bl cells that had been transduced with shRNAs targeting different IFITMs <sup><a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a></sup>. Infection of cells with virus produced during transfection was inhibited through the use of the CXCR4 antagonist AMD3100, and thus the level of viral output in our analysis cannot be confounded by entry inhibition due to IFITM expression. The efficiency of knockdown in IFITM expression was confirmed by immunoblotting using monoclonal antibodies specific for individual IFITMs (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Figure 3A</a>). As anticipated, IFN-β treatment reduced viral production in HIV-1 transfected TZM-bl cells (<a id="xref-fig-3-2" class="xref-fig" href="#F3">Figure 3B</a>). Despite some weak knockdown cross-reactivity, such that shRNA targeting IFITM1 caused weak knockdown of IFITM2 (<a id="xref-fig-3-3" class="xref-fig" href="#F3">Figure 3A</a>), and that it was not possible to knockdown IFITM3 in isolation, knockdown of both IFITM1 and IFITM2 clearly rescued the level of virus produced in IFN-β treated cells (<a id="xref-fig-3-4" class="xref-fig" href="#F3">Figure 3C</a>). Further, knockdown of all three IFITMs gave a higher rescue, indicating that the inhibitory effects of IFITM1 and IFITM2 on viral production are perhaps non-redundant in the context of HIV-1 replication. These effects were paired with rescue of all viral proteins levels during IFITM knockdown (<a id="xref-fig-3-5" class="xref-fig" href="#F3">Figure 3D</a> and <a id="xref-fig-3-6" class="xref-fig" href="#F3">3E</a>). Knockdown of IFITMs rescued viral protein production by around 1.5 to 3.5 fold, and so is concordant with viral production rescue of 2.0 to 2.5-fold. These data then show that endogenous levels of IFITMs can inhibit viral particle output and that our prior results in 293T transfections and SupT1 infections are not an overexpression artefact. They also suggest that IFITMs are a significant component of the antiviral response induced by type I interferon.</p><div id="F3" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Knockdown of IFITMs rescues HIV-1 output and viral protein production in TZM-bl cells TZM-bl cells transduced with shRNAs against the indicated IFITMs or scrambled control (sc) were treated with 100IU/ml IFN&#x3B2; for 72 hours. (A) Levels of IFITM expression were analyzed by immunoblotting. (B) Scrambled control TZM-bl cells were transfected with HIV-1 NL4-3 proviral DNA and treated with 100IU/ml IFN&#x3B2;. Level of virus production was measured by p24 ELISA 72h post-transfection. TZM-bl cells transduced with shRNAs against the indicated IFITMs or scrambled control were transfected with HIV-1 NL4-3 proviral DNA and then treated with AMD3100 and IFN&#x3B2; 4h post-transfection. Level of virus output and viral proteins was measured by (C) p24 ELISA and (D) immunoblotting, respectively, at 72 hours post-transfection. (E) Immunoblotting was further analyzed by densitometry. Data show mean + S.E.M. of 3 independent experiments. Differences were assessed with Student&#x2019;s t-test and * indicates p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1939130801" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Knockdown of IFITMs rescues HIV-1 output and viral protein production in TZM-bl cells&lt;/span&gt; TZM-bl cells transduced with shRNAs against the indicated IFITMs or scrambled control (sc) were treated with 100IU/ml IFN&#x3B2; for 72 hours. &lt;strong&gt;(A)&lt;/strong&gt; Levels of IFITM expression were analyzed by immunoblotting. &lt;strong&gt;(B)&lt;/strong&gt; Scrambled control TZM-bl cells were transfected with HIV-1 NL4-3 proviral DNA and treated with 100IU/ml IFN&#x3B2;. Level of virus production was measured by p24 ELISA 72h post-transfection. TZM-bl cells transduced with shRNAs against the indicated IFITMs or scrambled control were transfected with HIV-1 NL4-3 proviral DNA and then treated with AMD3100 and IFN&#x3B2; 4h post-transfection. Level of virus output and viral proteins was measured by &lt;strong&gt;(C)&lt;/strong&gt; p24 ELISA and &lt;strong&gt;(D)&lt;/strong&gt; immunoblotting, respectively, at 72 hours post-transfection. &lt;strong&gt;(E)&lt;/strong&gt; Immunoblotting was further analyzed by densitometry. Data show mean + S.E.M. of 3 independent experiments. Differences were assessed with Student&#x2019;s t-test and * indicates p&lt;0.05.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F3.medium.gif" width="440" height="368"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 3." src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F3.medium.gif" width="440" height="368"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 3.</span> <span class="caption-title">Knockdown of IFITMs rescues HIV-1 output and viral protein production in TZM-bl cells</span><p id="p-16" class="first-child">TZM-bl cells transduced with shRNAs against the indicated IFITMs or scrambled control (sc) were treated with 100IU/ml IFNβ for 72 hours. <strong>(A)</strong> Levels of IFITM expression were analyzed by immunoblotting. <strong>(B)</strong> Scrambled control TZM-bl cells were transfected with HIV-1 NL4-3 proviral DNA and treated with 100IU/ml IFNβ. Level of virus production was measured by p24 ELISA 72h post-transfection. TZM-bl cells transduced with shRNAs against the indicated IFITMs or scrambled control were transfected with HIV-1 NL4-3 proviral DNA and then treated with AMD3100 and IFNβ 4h post-transfection. Level of virus output and viral proteins was measured by <strong>(C)</strong> p24 ELISA and <strong>(D)</strong> immunoblotting, respectively, at 72 hours post-transfection. <strong>(E)</strong> Immunoblotting was further analyzed by densitometry. Data show mean + S.E.M. of 3 independent experiments. Differences were assessed with Student’s t-test and * indicates p&lt;0.05.</p><div class="sb-div caption-clear"></div></div></div><p id="p-17">We next sought to confirm if the knockdown of physiologically relevant levels of IFITMs in HIV-1 infected primary cells could rescue viral protein production. Primary human CD4<sup>+</sup> T cells were infected with HIV-1 following transduction with lentiviral particles for the expression of shRNAs targeting different IFITMs. Transduction with one shRNAs resulted in a specific ~90% downregulation of IFITM2, while another shRNA led to a ~50% downregulation of all three IFITMs (<a id="xref-fig-4-1" class="xref-fig" href="#F4">Figure 4A-C</a>). We were unable to specifically knockdown IFITM1 with reasonable efficiency. To mitigate the effects of IFITMs inhibiting viral entry on our studies of inhibited viral production, we took advantage of recent observations showing that different IFITM proteins vary in their inhibition of viral entry depending on HIV-1 co-receptor usage <sup><a id="xref-ref-16-5" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-22-3" class="xref-bibr" href="#ref-22">22</a>,<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a></sup>. IFITM1 inhibits entry of CCR5-tropic viruses and IFITM2/3 predominantly inhibits CXCR4-tropic viruses. We therefore studied viral production effects driven by IFITM2 and IFITM3 with dual-tropic HIV-1 89.6, wherein cells were treated with the CXCR4 antagonist AMD3100 prior to and during infection. AMD3100 treatment would direct viral entry via CCR5 due to CXCR4 blockade and thus mitigate entry inhibition by either IFITM2 or IFITM3. We used intracellular p24 staining of infected cells in single cycle infections to measure uptake of virus after infection with trypsin treatment to remove cell surface bound virus <sup><a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>–<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a></sup>. Although cellular uptake of viral p24 is not an exact measure of virus entry due to the uptake of virus into potentially non-productive endocytic pathways, p24 uptake is commonly found to be inhibited by IFITM expression <sup><a id="xref-ref-14-5" class="xref-bibr" href="#ref-14">14</a>,<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>,<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a></sup>, while endocytic uptake of virus occurs at a lower rate in primary CD4<sup>+</sup> T-cells <sup><a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a></sup>. We confirmed that viral uptake was minimally impeded with these during IFITM knockdown (<a id="xref-fig-4-2" class="xref-fig" href="#F4">Figure 4D and E</a>), consistent with prior observations <sup><a id="xref-ref-28-2" class="xref-bibr" href="#ref-28">28</a></sup>. Therefore reductions in virus production were considered to arise predominantly from IFITM-driven effects other than inhibition of viral entry. As such knockdown of IFITM2 led to a clear rescue of viral particle output (7-fold) that was coupled with rescue in viral protein expression (<a id="xref-fig-4-3" class="xref-fig" href="#F4">Figure 4F,G</a>). Similarly, knockdown of IFITM1-3 led to rescue of viral protein production and viral particle output (&gt;10-fold) (<a id="xref-fig-4-4" class="xref-fig" href="#F4">Figure 4F, G and H</a>). Though as IFITM1 which was depleted in this experiment can inhibit R5-tropic virus entry, a proportion of this latter result for IFITM1-3 may be attributable to weak IFITM1 driven entry inhibition. That this effect was very weak (<a id="xref-fig-4-5" class="xref-fig" href="#F4">Figure 4F and G</a>) suggests that viral production inhibition may be the dominant form of IFITM driven inhibition in this experiment. Overall, this confirms that physiologically relevant levels of IFITM proteins can clearly inhibit HIV-1 production in primary cells independent of their effects upon entry and infectivity, that this is not an overexpression artefact, and occurs in a manner that is consistent with our observations in cell lines.</p><div id="F4" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Knockdown of IFITMs rescues HIV-1 output and viral protein production in primary human T cells Activated human CD4+ T cells were transduced with lentivirus expressing the indicated shRNAs against IFITMs or scrambled sequence (sc) for 48 hours. (A) Level of IFITM expression was analyzed by immunoblotting and (B) densitometry; data was normalized to GAPDH and scrambled control. Cells were then infected with HIV-1 89.6 with equivalent p24 concentrations. Cells were pre-treated with AMD3100 for 2 hours prior to infection and throughout. viral proteins in infected cells was analyzed by immunoblotting. Immediately after infection, cells were treated with trypsin and washed with PBS before intracellular staining of p24 and flow cytometry to measure virus uptake. Intracellular levels of p24 and median fluorescence intensity are shown in (D) representative histograms and (E) summary bar chart. Levels of (F) viral proteins in infected cells from one of the blood donors were shown by (G) densitometry. (H) Level of virus production was measured by p24 ELISA 72 hours post-infection and normalized. Data show mean + S.E.M. of 2 blood donors. Differences were assessed with Student&#x2019;s t-test and * indicates p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1939130801" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Knockdown of IFITMs rescues HIV-1 output and viral protein production in primary human T cells&lt;/span&gt; Activated human CD4&lt;sup&gt;+&lt;/sup&gt; T cells were transduced with lentivirus expressing the indicated shRNAs against IFITMs or scrambled sequence (sc) for 48 hours. &lt;strong&gt;(A)&lt;/strong&gt; Level of IFITM expression was analyzed by immunoblotting and (B) densitometry; data was normalized to GAPDH and scrambled control. Cells were then infected with HIV-1 89.6 with equivalent p24 concentrations. Cells were pre-treated with AMD3100 for 2 hours prior to infection and throughout. viral proteins in infected cells was analyzed by immunoblotting. Immediately after infection, cells were treated with trypsin and washed with PBS before intracellular staining of p24 and flow cytometry to measure virus uptake. Intracellular levels of p24 and median fluorescence intensity are shown in &lt;strong&gt;(D)&lt;/strong&gt; representative histograms and &lt;strong&gt;(E)&lt;/strong&gt; summary bar chart. Levels of &lt;strong&gt;(F)&lt;/strong&gt; viral proteins in infected cells from one of the blood donors were shown by &lt;strong&gt;(G)&lt;/strong&gt; densitometry. &lt;strong&gt;(H)&lt;/strong&gt; Level of virus production was measured by p24 ELISA 72 hours post-infection and normalized. Data show mean + S.E.M. of 2 blood donors. Differences were assessed with Student&#x2019;s t-test and * indicates p&lt;0.05.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F4.medium.gif" width="440" height="391"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 4." src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F4.medium.gif" width="440" height="391"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 4." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 4.</span> <span class="caption-title">Knockdown of IFITMs rescues HIV-1 output and viral protein production in primary human T cells</span><p id="p-18" class="first-child">Activated human CD4<sup>+</sup> T cells were transduced with lentivirus expressing the indicated shRNAs against IFITMs or scrambled sequence (sc) for 48 hours. <strong>(A)</strong> Level of IFITM expression was analyzed by immunoblotting and (B) densitometry; data was normalized to GAPDH and scrambled control.</p><p id="p-19">Cells were then infected with HIV-1 89.6 with equivalent p24 concentrations. Cells were pre-treated with AMD3100 for 2 hours prior to infection and throughout. viral proteins in infected cells was analyzed by immunoblotting. Immediately after infection, cells were treated with trypsin and washed with PBS before intracellular staining of p24 and flow cytometry to measure virus uptake. Intracellular levels of p24 and median fluorescence intensity are shown in <strong>(D)</strong> representative histograms and <strong>(E)</strong> summary bar chart. Levels of <strong>(F)</strong> viral proteins in infected cells from one of the blood donors were shown by <strong>(G)</strong> densitometry. <strong>(H)</strong> Level of virus production was measured by p24 ELISA 72 hours post-infection and normalized. Data show mean + S.E.M. of 2 blood donors. Differences were assessed with Student’s t-test and * indicates p&lt;0.05.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-4" class="subsection"><h3>IFITMs restrict HIV-1 protein synthesis</h3><p id="p-20">As we found that IFITM expression was associated with losses in viral protein production and viral output, we next asked if IFITMs play a role in inhibiting the transcription or stability of viral mRNA by analyzing the level of unspliced, singly-spliced, and multiply-spliced transcripts detected by RT-qPCR from total RNA of whole cell lysates. IFITM1 and IFITM2 weakly reduced the levels of singly-spliced and multiply-spliced transcripts, while IFITM3 had no measureable effect (<a id="xref-fig-5-1" class="xref-fig" href="#F5">Figure 5A</a>). The total level of unspliced transcripts remained unaffected in the presence of IFITM proteins (<a id="xref-fig-5-2" class="xref-fig" href="#F5">Figure 5A</a>) but nonetheless there were reductions of intracellular level of Gag (a product of unspliced transcripts) in our prior analyses (<a id="xref-fig-1-8" class="xref-fig" href="#F1">Figures 1</a>–<a id="xref-fig-4-6" class="xref-fig" href="#F4">4</a>). This prompted us to investigate if IFITM proteins affect translation of viral transcripts.</p><div id="F5" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F5.large.jpg?width=800&amp;height=600&amp;carousel=1" title="IFITM proteins inhibit HIV-1 protein synthesis Activated human CD4+ T cells were transduced with lentivirus expressing the indicated shRNAs against IFITMs or scrambled sequence (sc) for 48 hours. (A) Level of IFITM expression was analyzed by immunoblotting and (B) densitometry; data was normalized to GAPDH and scrambled control. (A) Level of viral transcripts in HEK293T cells transfected with HIV-1 NL4-3 and IFITM DNA was measured by qPCR 48 hours post-transfection and the data normalized. (B) Level of RNA in sucrose gradient fractions of HEK293T cells transfected with proviral HIV-1 NL4-3 DNA and expression vectors for IFITMs (or vector alone) was measured by absorbance at 254nm. (C) Level of ribosomal protein L7 was analyzed by immunonblotting to identify fractions enriched for polysomes. (D) Level of GAPDH RNA in IFITM-expressing cells was normalized to vector control in the indicated sucrose gradient fractions. Level of (E) unspliced, (F) singly-spliced and (G) multiply-spliced viral transcripts in the indicated sucrose gradient fractions in (B) was analyzed by qPCR then normalized with the levels of GAPDH RNA and input RNA. Data shows mean + SEM of 3 independent experiments. Differences were assessed by Student&#x2019;s t-test and * denotes p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1939130801" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;IFITM proteins inhibit HIV-1 protein synthesis&lt;/span&gt; Activated human CD4&lt;sup&gt;+&lt;/sup&gt; T cells were transduced with lentivirus expressing the indicated shRNAs against IFITMs or scrambled sequence (sc) for 48 hours. &lt;strong&gt;(A)&lt;/strong&gt; Level of IFITM expression was analyzed by immunoblotting and (B) densitometry; data was normalized to GAPDH and scrambled control. &lt;strong&gt;(A)&lt;/strong&gt; Level of viral transcripts in HEK293T cells transfected with HIV-1 NL4-3 and IFITM DNA was measured by qPCR 48 hours post-transfection and the data normalized. &lt;strong&gt;(B)&lt;/strong&gt; Level of RNA in sucrose gradient fractions of HEK293T cells transfected with proviral HIV-1 NL4-3 DNA and expression vectors for IFITMs (or vector alone) was measured by absorbance at 254nm. &lt;strong&gt;(C)&lt;/strong&gt; Level of ribosomal protein L7 was analyzed by immunonblotting to identify fractions enriched for polysomes. &lt;strong&gt;(D)&lt;/strong&gt; Level of GAPDH RNA in IFITM-expressing cells was normalized to vector control in the indicated sucrose gradient fractions. Level of &lt;strong&gt;(E)&lt;/strong&gt; unspliced, &lt;strong&gt;(F)&lt;/strong&gt; singly-spliced and &lt;strong&gt;(G)&lt;/strong&gt; multiply-spliced viral transcripts in the indicated sucrose gradient fractions in &lt;strong&gt;(B)&lt;/strong&gt; was analyzed by qPCR then normalized with the levels of GAPDH RNA and input RNA. Data shows mean + SEM of 3 independent experiments. Differences were assessed by Student&#x2019;s t-test and * denotes p&lt;0.05 compared to vector control.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 5." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F5.medium.gif" width="440" height="207"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 5." src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F5.medium.gif" width="440" height="207"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F5.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 5." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 5.</span> <span class="caption-title">IFITM proteins inhibit HIV-1 protein synthesis</span><p id="p-21" class="first-child">Activated human CD4<sup>+</sup> T cells were transduced with lentivirus expressing the indicated shRNAs against IFITMs or scrambled sequence (sc) for 48 hours. <strong>(A)</strong> Level of IFITM expression was analyzed by immunoblotting and (B) densitometry; data was normalized to GAPDH and scrambled control.</p><p id="p-22"><strong>(A)</strong> Level of viral transcripts in HEK293T cells transfected with HIV-1 NL4-3 and IFITM DNA was measured by qPCR 48 hours post-transfection and the data normalized. <strong>(B)</strong> Level of RNA in sucrose gradient fractions of HEK293T cells transfected with proviral HIV-1 NL4-3 DNA and expression vectors for IFITMs (or vector alone) was measured by absorbance at 254nm. <strong>(C)</strong> Level of ribosomal protein L7 was analyzed by immunonblotting to identify fractions enriched for polysomes. <strong>(D)</strong> Level of GAPDH RNA in IFITM-expressing cells was normalized to vector control in the indicated sucrose gradient fractions. Level of <strong>(E)</strong> unspliced, <strong>(F)</strong> singly-spliced and <strong>(G)</strong> multiply-spliced viral transcripts in the indicated sucrose gradient fractions in <strong>(B)</strong> was analyzed by qPCR then normalized with the levels of GAPDH RNA and input RNA. Data shows mean + SEM of 3 independent experiments. Differences were assessed by Student’s t-test and * denotes p&lt;0.05 compared to vector control.</p><div class="sb-div caption-clear"></div></div></div><p id="p-23">To achieve this we performed a polysome analysis for HIV-1 transcripts during IFITM expression. We first analyzed the RNA content in cell lysates fractionated on a sucrose gradient by ultracentrifugation. The total RNA profiles (<a id="xref-fig-5-3" class="xref-fig" href="#F5">Figure 5B</a>) RNA recovered from selected fractions of virus producing cells expressing IFITMs are comparable to vector-transfected control, suggesting that IFITM expression did not alter global translation in the cell. We used the level of ribosomal protein L7 as a guide for selection of fractions in our analysis (<a id="xref-fig-5-4" class="xref-fig" href="#F5">Figure 5C</a>) as it is a component of 60S ribosomes, which are enriched in 80S monosomes (such as fraction 10 <a id="xref-fig-5-5" class="xref-fig" href="#F5">Figure 5C</a>) as well as polysomes (such as fractions 14-18. The levels of GAPDH mRNA were not reduced in polysome fractions. Reductions in the levels of viral transcripts in polysome fractions (in contrast to whole cell lysates – <a id="xref-fig-5-6" class="xref-fig" href="#F5">Figure 5A</a>) would indicate specific translational inhibition. As such, we analyzed the level of viral transcripts in selected fractions covering the whole RNA profile with RT-qPCR.). IFITM1 and IFITM2 significantly reduced the level of unspliced and singly-spliced viral transcripts in polysomes (<a id="xref-fig-5-7" class="xref-fig" href="#F5">Figure 5E and F</a>) and increased the level of these transcripts in the ribosome-free fraction (fraction 6), suggesting that expression of IFITM1 and IFITM2 inhibited translation of these viral transcripts. IFITM1 and IFITM2 also appeared to somewhat reduce the level of multiply-spliced transcripts (<a id="xref-fig-5-8" class="xref-fig" href="#F5">Figure 5G</a>), though the effect did not reach statistical significance, but was nonetheless coupled with a clear accumulation of ribosome-free multiply-spliced transcripts in low concentration sucrose fraction (<a id="xref-fig-5-9" class="xref-fig" href="#F5">Figure 5G</a> - fraction 6) relative to vector control, similar to other viral transcript classes. These data were consistent with our analysis of viral production (<a id="xref-fig-1-9" class="xref-fig" href="#F1">Figure 1</a>) wherein IFITM1 and IFITM2 expression lead to a more potent block in viral production than for IFITM3. Thus IFITM proteins inhibit translation of HIV-1 transcripts by leading to their specific exclusion from polysomes, resulting in reduced levels viral proteins and reduced viral output.</p></div><div id="sec-5" class="subsection"><h3>HIV-1 RNA is a determinant of IFITM-mediated restriction of protein synthesis</h3><p id="p-24">To better understand how IFITM proteins help suppressing viral translation, we explored the possibility that they may be involved in a process that is able to distinguish viral RNA from cellular RNA. To address this, we measured the level of unspliced viral RNA transcripts in the polysome fraction of HEK293T cells transfected with a codon-optimized vector for HIV-1 NL4-3 Gag only <sup><a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a></sup> in conjunction with IFITM-expression vectors. Codon-optimization changes the codon bias of the construct towards and therefore also alters the secondary structures of viral RNA. Changing codon bias thus renders HIV-1 unspliced and singly-spliced transcript expression independent of the HIV Rev responsive element (RRE), a <em>cis</em> acting RNA structure necessary for transcript nuclear export <sup><a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a></sup>. Codon optimization of <em>gag</em> rescued the level of unspliced HIV-1 transcripts in polysomes during IFITM expression, nor was there an accumulation of transcripts in low sucrose fractions as was seen with wild type NL4-3 (fraction 7 in <a id="xref-fig-6-1" class="xref-fig" href="#F6">Figure 6A</a> compared to fractions 6 in <a id="xref-fig-5-10" class="xref-fig" href="#F5">Figure 5E, F and G</a>). As a result, the level of extracellular p24 production from cells expressing IFITM1 and IFITM2 was not only rescued but enhanced, and the production of the <em>gag</em> products p55 and p24 was also restored (<a id="xref-fig-6-2" class="xref-fig" href="#F6">Figure 6B, C and F</a>). Notably p24 protein production was only partially rescued, but p55 was entirely rescued (<a id="xref-fig-6-3" class="xref-fig" href="#F6">Figure 6F</a>). Contrasting data for full length pNL4-3 DNA show clear losses of viral production and protein expression in similar experiments (<a id="xref-fig-6-4" class="xref-fig" href="#F6">Figure 6D, E and F</a>).</p><div id="F6" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F6.large.jpg?width=800&amp;height=600&amp;carousel=1" title="HIV-1 RNA is a determinant of IFITM-mediated inhibition of protein synthesis (A) Normalized levels of unspliced viral transcripts (measured by qPCR) in the polysome fractions of HEK293T cells transfected with codon-optimized HIV-1 NL4-3 Gag DNA and IFITM expression vectors at 48h post-transfection. (B) Levels of extracellular p24 in HEK293T cells transfected with codon-optimized HIV-1 Gag DNA measured by p24 ELISA 48h post-transfection and normalized. Cellular levels of HIV-1 Gag (p55 and p24) were analyzed by (C) immunoblotting. (D) Levels of virus production in HEK293T cells transfected with 0.5&#x3BC;g wild-type HIV-1 NL4-3 proviral DNA and 0.5&#x3BC;g IFITM-expression plasmids or empty vector was measured by p24 ELISA 48 hours post-transfection and normalized. Cellular levels of HIV-1 Gag (p55 and p24) in cells transfected were analyzed by (E) immunoblotting and (F) densitometry. Data show mean + SEM of 3 independent experiments and differences were assessed by Student&#x2019;s t-test, * denotes p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1939130801" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;HIV-1 RNA is a determinant of IFITM-mediated inhibition of protein synthesis&lt;/span&gt; &lt;strong&gt;(A)&lt;/strong&gt; Normalized levels of unspliced viral transcripts (measured by qPCR) in the polysome fractions of HEK293T cells transfected with codon-optimized HIV-1 NL4-3 Gag DNA and IFITM expression vectors at 48h post-transfection. &lt;strong&gt;(B)&lt;/strong&gt; Levels of extracellular p24 in HEK293T cells transfected with codon-optimized HIV-1 Gag DNA measured by p24 ELISA 48h post-transfection and normalized. Cellular levels of HIV-1 Gag (p55 and p24) were analyzed by &lt;strong&gt;(C)&lt;/strong&gt; immunoblotting. &lt;strong&gt;(D)&lt;/strong&gt; Levels of virus production in HEK293T cells transfected with 0.5&#x3BC;g wild-type HIV-1 NL4-3 proviral DNA and 0.5&#x3BC;g IFITM-expression plasmids or empty vector was measured by p24 ELISA 48 hours post-transfection and normalized. Cellular levels of HIV-1 Gag (p55 and p24) in cells transfected were analyzed by &lt;strong&gt;(E)&lt;/strong&gt; immunoblotting and &lt;strong&gt;(F)&lt;/strong&gt; densitometry. Data show mean + SEM of 3 independent experiments and differences were assessed by Student&#x2019;s t-test, * denotes p&lt;0.05 compared to vector control.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 6." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F6.medium.gif" width="440" height="335"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 6." src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F6.medium.gif" width="440" height="335"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F6.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 6." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F6.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 6.</span> <span class="caption-title">HIV-1 RNA is a determinant of IFITM-mediated inhibition of protein synthesis</span><p id="p-25" class="first-child"><strong>(A)</strong> Normalized levels of unspliced viral transcripts (measured by qPCR) in the polysome fractions of HEK293T cells transfected with codon-optimized HIV-1 NL4-3 Gag DNA and IFITM expression vectors at 48h post-transfection. <strong>(B)</strong> Levels of extracellular p24 in HEK293T cells transfected with codon-optimized HIV-1 Gag DNA measured by p24 ELISA 48h post-transfection and normalized. Cellular levels of HIV-1 Gag (p55 and p24) were analyzed by <strong>(C)</strong> immunoblotting.</p><p id="p-26"><strong>(D)</strong> Levels of virus production in HEK293T cells transfected with 0.5μg wild-type HIV-1 NL4-3 proviral DNA and 0.5μg IFITM-expression plasmids or empty vector was measured by p24 ELISA 48 hours post-transfection and normalized. Cellular levels of HIV-1 Gag (p55 and p24) in cells transfected were analyzed by <strong>(E)</strong> immunoblotting and <strong>(F)</strong> densitometry. Data show mean + SEM of 3 independent experiments and differences were assessed by Student’s t-test, * denotes p&lt;0.05 compared to vector control.</p><div class="sb-div caption-clear"></div></div></div><p id="p-27">We then sought to identify specific RNA features that may render HIV-1 susceptible to an IFITM-driven translational block. As our findings of transfected HEK293T cells showed that unspliced and singly-spliced viral transcripts are more readily excluded from polysomes by IFITM proteins than multiply-spliced transcripts in those cells (<a id="xref-fig-5-11" class="xref-fig" href="#F5">Figure 5</a>), we reasoned that RRE, which is present in only unspliced and singly-spliced transcripts may be somehow recognized during IFITM protein expression leading to translational inhibition. To address this, we exploited constructs in which singly-spliced and unspliced transcripts had been rendered RRE and Rev independent via the introduction of the Mason Pfizer Monkey Virus (MPMV) constitutive transport element (CTE) <sup><a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a></sup>. A modification which allows all transcripts to be exported from the nucleus by the cellular TAP/NXT1 pathway, rather than RRE bearing Rev-dependent transcripts exporting via the CRM1 pathway <sup><a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a></sup>. We found that CTE dependent Rev independent virus was still inhibited by IFITM proteins (Figure S3), demonstrating at least that nuclear export pathway does not affect the virus production inhibition seen with IFITM proteins. Further introduction of the RRE into CTE bearing constructs did also not augment the restriction.</p><p id="p-28">Overall, these data suggest that the restriction of translation by IFITMs occurs at the RNA level, though it is not clear that the RRE plays a significant role in susceptibility, despite that RRE bearing transcripts are more affected in translation. Therefore some other distinguishing feature of viral transcripts or translation determines their susceptibility to IFITM proteins.</p></div><div id="sec-6" class="subsection"><h3>HIV Nef can help overcome IFITM-mediated restriction of virus production</h3><p id="p-29">Under the selective pressure of cellular restriction factors, retroviruses have evolved to counteract surveillance and restriction by host antiviral factors (reviewed in <sup><a id="xref-ref-1-2" class="xref-bibr" href="#ref-1">1</a></sup>). We therefore sought to investigate if HIV is able to counteract the restriction of viral production by IFITM proteins. We reasoned that HIV-1 Nef may influence this process. IFITMs are membrane proteins and lentiviral Nef regulates the trafficking of many membrane proteins such as CD4, MHC-I and tetherin to aid immune evasion and viral replication <sup><a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>–<a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a></sup>. Further, the expression of a dominant negative form of HIV-1 Nef <sup><a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a></sup>, or <em>nef</em> deletion has previously been linked to deficits in viral production <sup><a id="xref-ref-41-1" class="xref-bibr" href="#ref-41">41</a></sup>.</p><p id="p-30">We therefore measured the level of virus production in HEK293T cells transfected with expression vectors of IFITMs with wild type or <em>nef-</em>deleted HIV-1 NL4-3 proviral DNA. The level of <em>nef</em>-deleted virus produced was inhibited 18-fold by IFITM1, 21-fold by IFITM2 and 5-fold for IFITM3, suggesting a 4-fold enhancement of virus production due to HIV-1 Nef during IFITM1 and IFITM2 expression (<a id="xref-fig-7-1" class="xref-fig" href="#F7">Figure 7A</a>). We confirmed a significant reduction in HIV-1 Gag (p55) levels in cells producing <em>nef</em>-deleted virus while IFITMs are expressed (<a id="xref-fig-7-2" class="xref-fig" href="#F7">Figure 7B</a>, S4B), indicating that Nef may rescue the translational suppression driven by IFITMs. As these data were generated through transfection, they were independent of any influence of Nef upon viral entry <sup><a id="xref-ref-7-2" class="xref-bibr" href="#ref-7">7</a>,<a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">8</a></sup>. It is also of note that exogenous IFITM levels were not reduced by HIV-1 Nef, perhaps indicating that antagonism of IFITM proteins may not occur via degradation (<a id="xref-fig-7-3" class="xref-fig" href="#F7">Figure 7B</a>).</p><div id="F7" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F7.large.jpg?width=800&amp;height=600&amp;carousel=1" title="HIV Nef can help overcome IFITM-mediated restriction of protein synthesis (A) Level of virus production in HEK293T cells transfected with 0.5&#x3BC;g expression vectors for IFITMs and 0.5&#x3BC;g HIV-1 NL4-3 proviral DNA with a deletion (&#x394;Nef) was measured by p24 ELISA 48 hours post-transfection and the data normalized, fold change of virus production compared to vector control is indicated. Differences were assessed with Student&#x2019;s t tests. (B) Intracellular level of p55/p24 and IFITMs was measured by immunoblotting. (C) SupT1 cells were infected with the indicated dilutions of wild type or Nef-deleted (&#x394;Nef) HIV-1 NL4-3 inoculum and then treated with 1&#x3BC;g/ml doxycycline to induce IFITM expression post-entry and 5&#x3BC;M AMD3100 to limit infections to a single round. Level of virus production was measured by p24 ELISA 72 hours post-infection. Differences were assessed with Two-way ANOVA and Bonferroni post-tests. (D) C8166 cells constitutively expressing either vector control or IFITM1 were infected with either wild type or Nef-deleted (&#x394;Nef) HIV-1 NL4-3. Levels of virus production were measured by p24 ELISA at the indicated time-points post-infection and were normalized to the levels of virus produced from vector controls. Differences were assessed with Two-way ANOVA. (E) HEK293T cells were transfected with 0.5&#x3BC;g expression vectors for IFITMs and 0.5&#x3BC;g HIV-1 NL4-3 proviral DNA with either wildtype NL4-3 nef or the indicated lentiviral nef alleles. Virus production was measured by p24 ELISA 48 hours post-transfection and the data normalized. Differences were assessed with Student&#x2019;s t tests. (F) HEK293T cells were transfected with &#x394;Nef HIV-1 NL4-3 proviral DNA, expression vectors for IFITMs and an increasing proportion of HIV-1 Nef-encoding vector versus empty vector in a fixed total quantity of 1&#x3BC;g. Level of virus production was measured by p24 ELISA 48 hours post-transfection, while levels of viral proteins and IFITM-FLAG expression was analyzed by (G) immunoblotting. Differences were assessed by Student&#x2019;s t-test. All data show mean + SEM from 3 independent experiments and * denotes p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1939130801" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;HIV Nef can help overcome IFITM-mediated restriction of protein synthesis&lt;/span&gt; &lt;strong&gt;(A)&lt;/strong&gt; Level of virus production in HEK293T cells transfected with 0.5&#x3BC;g expression vectors for IFITMs and 0.5&#x3BC;g HIV-1 NL4-3 proviral DNA with a deletion (&#x394;Nef) was measured by p24 ELISA 48 hours post-transfection and the data normalized, fold change of virus production compared to vector control is indicated. Differences were assessed with Student&#x2019;s t tests. &lt;strong&gt;(B)&lt;/strong&gt; Intracellular level of p55/p24 and IFITMs was measured by immunoblotting. &lt;strong&gt;(C)&lt;/strong&gt; SupT1 cells were infected with the indicated dilutions of wild type or Nef-deleted (&#x394;Nef) HIV-1 NL4-3 inoculum and then treated with 1&#x3BC;g/ml doxycycline to induce IFITM expression post-entry and 5&#x3BC;M AMD3100 to limit infections to a single round. Level of virus production was measured by p24 ELISA 72 hours post-infection. Differences were assessed with Two-way ANOVA and Bonferroni post-tests. &lt;strong&gt;(D)&lt;/strong&gt; C8166 cells constitutively expressing either vector control or IFITM1 were infected with either wild type or Nef-deleted (&#x394;Nef) HIV-1 NL4-3. Levels of virus production were measured by p24 ELISA at the indicated time-points post-infection and were normalized to the levels of virus produced from vector controls. Differences were assessed with Two-way ANOVA. &lt;strong&gt;(E)&lt;/strong&gt; HEK293T cells were transfected with 0.5&#x3BC;g expression vectors for IFITMs and 0.5&#x3BC;g HIV-1 NL4-3 proviral DNA with either wildtype NL4-3 &lt;em&gt;nef&lt;/em&gt; or the indicated lentiviral &lt;em&gt;nef&lt;/em&gt; alleles. Virus production was measured by p24 ELISA 48 hours post-transfection and the data normalized. Differences were assessed with Student&#x2019;s t tests. &lt;strong&gt;(F)&lt;/strong&gt; HEK293T cells were transfected with &#x394;Nef HIV-1 NL4-3 proviral DNA, expression vectors for IFITMs and an increasing proportion of HIV-1 Nef-encoding vector versus empty vector in a fixed total quantity of 1&#x3BC;g. Level of virus production was measured by p24 ELISA 48 hours post-transfection, while levels of viral proteins and IFITM-FLAG expression was analyzed by &lt;strong&gt;(G)&lt;/strong&gt; immunoblotting. Differences were assessed by Student&#x2019;s t-test. All data show mean + SEM from 3 independent experiments and * denotes p&lt;0.05.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 7." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F7.medium.gif" width="440" height="331"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 7." src="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F7.medium.gif" width="440" height="331"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F7.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 7." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2018/04/11/201525/F7.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 7.</span> <span class="caption-title">HIV Nef can help overcome IFITM-mediated restriction of protein synthesis</span><p id="p-31" class="first-child"><strong>(A)</strong> Level of virus production in HEK293T cells transfected with 0.5μg expression vectors for IFITMs and 0.5μg HIV-1 NL4-3 proviral DNA with a deletion (ΔNef) was measured by p24 ELISA 48 hours post-transfection and the data normalized, fold change of virus production compared to vector control is indicated. Differences were assessed with Student’s t tests. <strong>(B)</strong> Intracellular level of p55/p24 and IFITMs was measured by immunoblotting.</p><p id="p-32"><strong>(C)</strong> SupT1 cells were infected with the indicated dilutions of wild type or Nef-deleted (ΔNef) HIV-1 NL4-3 inoculum and then treated with 1μg/ml doxycycline to induce IFITM expression post-entry and 5μM AMD3100 to limit infections to a single round. Level of virus production was measured by p24 ELISA 72 hours post-infection. Differences were assessed with Two-way ANOVA and Bonferroni post-tests.</p><p id="p-33"><strong>(D)</strong> C8166 cells constitutively expressing either vector control or IFITM1 were infected with either wild type or Nef-deleted (ΔNef) HIV-1 NL4-3. Levels of virus production were measured by p24 ELISA at the indicated time-points post-infection and were normalized to the levels of virus produced from vector controls. Differences were assessed with Two-way ANOVA.</p><p id="p-34"><strong>(E)</strong> HEK293T cells were transfected with 0.5μg expression vectors for IFITMs and 0.5μg HIV-1 NL4-3 proviral DNA with either wildtype NL4-3 <em>nef</em> or the indicated lentiviral <em>nef</em> alleles. Virus production was measured by p24 ELISA 48 hours post-transfection and the data normalized. Differences were assessed with Student’s t tests.</p><p id="p-35"><strong>(F)</strong> HEK293T cells were transfected with ΔNef HIV-1 NL4-3 proviral DNA, expression vectors for IFITMs and an increasing proportion of HIV-1 Nef-encoding vector versus empty vector in a fixed total quantity of 1μg. Level of virus production was measured by p24 ELISA 48 hours post-transfection, while levels of viral proteins and IFITM-FLAG expression was analyzed by <strong>(G)</strong> immunoblotting. Differences were assessed by Student’s t-test. All data show mean + SEM from 3 independent experiments and * denotes p&lt;0.05.</p><div class="sb-div caption-clear"></div></div></div><p id="p-36">We next investigated if Nef presented an advantage to viral growth in infected T-cells. We infected SupT1 cells with either wild type or <em>nef</em>-deleted NL4-3 virus by post-entry induction of IFITM expression via doxycycline (<a id="xref-fig-7-4" class="xref-fig" href="#F7">Figure 7C</a>). As <em>nef</em>-deleted virus has an inherent growth defect, we normalized the quantity of wild type and <em>nef</em>-deleted virus produced from IFITM-induced cells to vector control cells. We chose to induce IFITMs after X4-tropic HIV-1 NL4-3 entry and limit infections to a single round through the use of the CXCR4 antagonist AMD3100 after infection to mitigate the influence of IFITMs upon viral entry. In this regard, we found that <em>nef-</em>deleted virus was no more susceptible to IFITM-mediated restriction of entry than wild type virus (Figure S4A). Compared to wild type virus, production of <em>nef</em>-deleted virus in infected SupT1 cells was reduced significantly during IFITM expression, surprisingly IFITM3 showed the greatest degree of rescue in SupT1 cells (<a id="xref-fig-7-5" class="xref-fig" href="#F7">Figure 7C</a>), in contrast to data for transfected 293T cells (<a id="xref-fig-7-6" class="xref-fig" href="#F7">Figure 7A and B</a>).</p><p id="p-37">To further confirm the role of IFITM1 in suppressing virus production in T cells, we monitored the production of either wild type or <em>nef</em>-deleted HIV-1 NL4-3 virus in multiple cycle infections in a C8166 T-cell line transduced to constitutively over-express IFITM1. As IFITM1 does not typically affect the entry of CXCR4-tropic virus such as NL4-3 (<a id="xref-fig-4-7" class="xref-fig" href="#F4">Figure 4A, B</a> and <sup><a id="xref-ref-10-6" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-28-3" class="xref-bibr" href="#ref-28">28</a></sup>), any difference in replication measured between wild type and <em>nef</em>-deleted virus could only arise from IFITM1-mediated effects on viral production, not cell entry. Therefore this experiment was not pursued for IFITM2 and IFITM3, as their constitutive expression would inhibit NL4-3 virus entry and complicate interpretation. We found that in the presence of IFITM1, the growth of <em>nef</em>-deleted virus was significantly reduced relative to wild type virus, with wild type virus showing 2-fold inhibition at 5 days post-infection, while <em>nef</em>-deleted virus was inhibited 5-fold by IFITM1 (<a id="xref-fig-7-7" class="xref-fig" href="#F7">Figure 7D</a>). As wild type and <em>nef</em>-deleted virus data in C8166 cells were individually normalized to the same viruses in C8166 vector control cells, the differences observed are not likely due to Nef overcoming SERINC3/5 expression <sup><a id="xref-ref-7-3" class="xref-bibr" href="#ref-7">7</a>,<a id="xref-ref-8-3" class="xref-bibr" href="#ref-8">8</a></sup>, as these factors would be similarly present in both cell lines. Interestingly, the benefit of Nef expression in the context of IFITM1 was lost in the later stages of viral culture, when cell-to-cell infection typically predominates <sup><a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">42</a></sup>. As <em>nef</em>-deleted virus was no more susceptible to IFITM-mediated restriction of entry than wild type virus (Figure S4A), these findings are only due to the influence of Nef to partially rescue virus production as seen in 293T cell transfections and SupT1 infections (<a id="xref-fig-7-8" class="xref-fig" href="#F7">Figure 7A-C</a>).</p><p id="p-38">We then investigated if Nef from other lentiviruses was able to overcome IFITM-mediated inhibition of protein synthesis using an HIV-1 NL4-3 plasmid proviral DNA into which lentiviral <em>nef</em> alleles had been substituted <sup><a id="xref-ref-43-1" class="xref-bibr" href="#ref-43">43</a></sup>. The level of virus production for HIV-1 NL4-3 bearing other <em>nef</em> alleles during IFITM expression was generally comparable to levels for wild type NL4-3 <em>nef</em> (<a id="xref-fig-7-9" class="xref-fig" href="#F7">Figure 7E</a>), indicating that ability of lentiviral Nef proteins to overcome IFITM mediated restriction of virus production is common.</p><p id="p-39">To further confirm the role of Nef in antagonizing IFITMs, we titrated a plasmid bearing NA7 <em>nef</em> into cells transfected with IFITM expression plasmids and <em>nef</em>-deleted NL4-3 proviral HIV-1 DNA. Nef expression <em>in trans</em> rescued viral production from IFITM-mediated inhibition in a dose dependent manner (<a id="xref-fig-7-10" class="xref-fig" href="#F7">Figure 7F</a>). However, we note overexpression of Nef in cells transfected with 0.5μg Nef-encoding plasmid resulted in a overall lower level of viral proteins compared with cells expressing lower levels of Nef. Interestingly, increased Nef levels helped restore viral production in the context of IFITM expression (<a id="xref-fig-7-11" class="xref-fig" href="#F7">Figure 7F</a>), this rescue was not reflected in viral protein production levels (<a id="xref-fig-7-12" class="xref-fig" href="#F7">Figure 7G</a> and S4C), implying that the ability of Nef to rescue HIV production during IFITM expression does not occur at the level of protein synthesis. In summary, these data show that Nef can help overcome IFITM-mediated inhibition of HIV-1 production in a concentration-dependent manner. Taken together, our data demonstrate that HIV-1 Nef is able to help overcome the inhibition of viral protein production exerted by IFITM proteins and therefore enhance infection.</p></div></div><div class="section" id="sec-7"><h2 class="">Discussion</h2><p id="p-40">We report here that IFITM protein restrict HIV-1 by excluding viral mRNA from polysomes thereby specifically inhibiting protein synthesis. By variously using transfection, post-entry IFITM induction, and viral co-receptor bypass strategies, we have identified a viral entry independent effect due to IFITMs that inhibits viral production. Since the discovery of the antiviral effect of IFITM proteins upon HIV-1 entry and infectivity, there have been data suggesting that there may be a distinct IFITM function directed towards HIV-1 production <sup><a id="xref-ref-10-7" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-12-4" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-14-6" class="xref-bibr" href="#ref-14">14</a>,<a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-22-4" class="xref-bibr" href="#ref-22">22</a>–<a id="xref-ref-26-3" class="xref-bibr" href="#ref-26">26</a></sup>. Despite the relative frequency of these passing observations on viral production, the underlying processes leading to loss of viral production during IFITM expression have not been explored.</p><p id="p-41">We have demonstrated the breadth of the IFITM-mediated restriction of virus production, identified the viral replication process that is subverted, and determined a means by which HIV-1 may partially overcome this effect. In addition, we find that restriction of viral production by IFITM proteins is clear contributor towards the inhibition of HIV-1 production seen in cells exposed to type I interferon, and have also shown that inhibition occurs in primary CD4<sup>+</sup> T-cells at physiologically relevant levels of endogenous IFITM expression. From a mechanistic perspective we have shown that HIV-1 RNA is the target of this inhibition, though the viral determinant remains elusive. We therefore propose that inhibition of viral protein synthesis is a genuine antiviral function exerted by IFITM proteins that is distinct from previously described effects upon entry and infectivity.</p><p id="p-42">Initial suggestions of a late-stage IFITM-mediated restriction have typically surrounded two common laboratory HIV-1 strains, NL4-3 and BH10 <sup><a id="xref-ref-10-8" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-12-5" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-14-7" class="xref-bibr" href="#ref-14">14</a>,<a id="xref-ref-25-2" class="xref-bibr" href="#ref-25">25</a>,<a id="xref-ref-26-4" class="xref-bibr" href="#ref-26">26</a></sup>. However, for the putative anti-HIV restriction factor viperin/RSAD2, analysis demonstrated that the phenotype could not be replicated beyond the laboratory strain NL4-3 <sup><a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">44</a></sup>. Therefore our demonstration that IFITM proteins restrict production of multiple HIV-1, HIV-2 and SIVs implies the phenotype we observe is likely not an artefact. This is supported by our finding that African Green Monkey IFITM1 can exert a similar antiviral effect upon HIV-1 production as occurs with human IFITM1.</p><p id="p-43">The general mechanism of restriction we outline is specific exclusion of HIV-1 mRNA from polysomes during IFITM expression. In HEK293T cells the effect principally occurs with IFITM1 and IFITM2, but less so for IFITM3 was generally consistent throughout our analysis. Yet inducible expression of IFITM3 in SupT1 cells showed an equivalent antiviral effect to IFITM1 and IFITM2, though, and this was also linked to viral protein loss and was independent of IFITM-driven effects on viral entry. We consider that the same translational blocks measured in polysome analysis of HEK293T cells drive the result seen in SupT1 cells and primary CD4<sup>+</sup> T-cells. Indeed, we considered it very likely cell type specific differences would occur, as IFITM localization and thus antiviral activity are governed by both ubiquitylation and palmitoylation <sup><a id="xref-ref-24-2" class="xref-bibr" href="#ref-24">24</a>,<a id="xref-ref-45-1" class="xref-bibr" href="#ref-45">45</a></sup>. Reasonably the degree to which IFITM-driven viral entry inhibition or viral translation inhibition occurs in particular cells is then influenced by the activity of these pathways, which are known to commonly vary. Equally, other cell specific factors influencing viral transcription (such as NFkB translocation) might also account for variation in antiviral activity between cell lines, as higher virus transcriptional activity may overcome inhibition. However, it is important to note that we were able to clearly confirm the inhibition of viral production in primary human CD4<sup>+</sup> T-cells by IFITM2 and IFITM1-3, demonstrating that inhibition of viral production by IFITMs occurs in HIV-1 target cells at physiologically relevant levels of endogenously expressed IFITM proteins.</p><p id="p-44">Why IFITM1 and IFITM2 should act similarly in many instances, when IFITM2 and IFITM3 have closer amino acid sequence identity and display greater overlap in cellular localization is not yet clear <sup><a id="xref-ref-10-9" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">19</a>,<a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">46</a>,<a id="xref-ref-47-1" class="xref-bibr" href="#ref-47">47</a></sup>. IFITM-mediated antiviral effects upon viral entry are principally determined by cellular localization, and we anticipate the inhibition of protein synthesis to be similar <sup><a id="xref-ref-45-2" class="xref-bibr" href="#ref-45">45</a>,<a id="xref-ref-46-2" class="xref-bibr" href="#ref-46">46</a>,<a id="xref-ref-48-1" class="xref-bibr" href="#ref-48">48</a></sup>. This is pertinent for differences we find between IFITM2 and IFITM3. Despite their high sequence similarity, they typically show distinct cellular localization.</p><p id="p-45">The exclusion of viral transcripts from polysomes mainly seemed to mainly affect unspliced and singly-spliced transcripts. Yet despite a lack of significance, there was consistent but weaker loss of multiply spliced transcripts from polysome fractions, coupled with multiply-spliced transcript enrichment in low sucrose fractions. This is perhaps indicative of some degree of multiply-spliced transcript translational blockage that explains the loss of Nef protein seen throughout our experiments.</p><p id="p-46">We saw no change in total unspliced mRNA levels in IFITM expressing cells yet there was modest depletion of singly-spliced and multiply-spliced mRNA during IFITM1 and IFITM2 expression. Though this overall depletion of total viral mRNA levels may partially account for some loss of Vpu and Nef production, polysome analysis additionally demonstrated clear exclusion of these transcript classes from translation. Why these overall mRNA levels should be reduced is of interest. One possibility is a transcriptional inhibition or pre-translational degradation, but degradation of mRNAs that have been inhibited in translation is thought to be common <sup><a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">49</a></sup>. For example, the antiviral protein ZAP, which degrades retroviral mRNA has also been shown to stall translation prior to mRNA degradation, illustrating the fluid link between translational stalling and mRNA stability <sup><a id="xref-ref-50-1" class="xref-bibr" href="#ref-50">50</a>,<a id="xref-ref-51-1" class="xref-bibr" href="#ref-51">51</a></sup>.</p><p id="p-47">Susceptibility to inhibition occurred at the level of viral mRNA and we so sought to identify a viral RNA susceptibility determinant. Our data showing <em>gag</em> codon optimization relieves the late-stage IFITM inhibition of HIV-1 supports similar findings <sup><a id="xref-ref-26-5" class="xref-bibr" href="#ref-26">26</a></sup>. Singly-spliced and unspliced transcripts that bear the RRE were typically most affected by IFITMs proteins in our analyses. Yet investigation of proviral constructs in which the RRE was substituted for the CTE element were inconclusive, making it difficult to reconcile a role for the RRE in determining inhibition, despite the appealing observation that RRE bearing transcripts are typically most affected. Notably, RRE bearing transcripts also have a non-human codon bias and surrounding splice sites that may prove to influence restriction <sup><a id="xref-ref-52-1" class="xref-bibr" href="#ref-52">52</a>–<a id="xref-ref-55-1" class="xref-bibr" href="#ref-55">55</a></sup>. As such further analysis to identify any HIV-1 RNA determinant of inhibition will then be of much value, though currently our further attempts to identify the viral RNA determinant have been unsuccessful. A recent study demonstrated that viral RNA CG dinucleotide frequency drives ZAP-mediated viral restriction, rather than a specific RNA structural determinants, thus the determinant for IFITM-mediated restriction of protein synthesis may be similarly obscure <sup><a id="xref-ref-56-1" class="xref-bibr" href="#ref-56">56</a></sup>. However, we were able to exclude the broader possibility of general translational arrest via IFITM expression. Other aspects of the mechanism remain elusive also. IFITMs have no reported RNA binding domain and so would require either an RNA-binding partner to directly achieve inhibition, or would need to be involved in a pathway that could influence translation in this manner.</p><p id="p-48">If IFITMs are cofactors in direct inhibition of viral RNA translation, it is not yet clear how a membrane protein can affect both soluble protein translation and membrane protein translation, this may ultimately depend the absolute strictness of translational site partitioning, a concept which is under renewed debate <sup><a id="xref-ref-57-1" class="xref-bibr" href="#ref-57">57</a></sup>. Further, typically a proportion of IFITM proteins in cells are not palmitoylated, and show less distinct membrane localization, conceivably this fraction may be important in influencing translation <sup><a id="xref-ref-45-3" class="xref-bibr" href="#ref-45">45</a></sup>. One unexplored possibility is that the capacity of IFITM proteins to disrupt membrane fluidity or other membrane physical characteristics to inhibition viral-cell membrane fusion <sup><a id="xref-ref-17-2" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-58-1" class="xref-bibr" href="#ref-58">58</a></sup> on the cell surface and in endosomal compartments similarly affects rough endoplasmic reticulum membranes, leading to a disruption of membrane bound translational complexes. Though how such a process could be specific to virus translation is unclear.</p><p id="p-49">We demonstrate that the lentiviral protein Nef can help overcome the late-stage inhibition of viral production exerted by IFITM proteins. Though notably this rescue is not complete. Our data may help explain accounts of a Nef driven enhancement of HIV-1 production <sup><a id="xref-ref-40-2" class="xref-bibr" href="#ref-40">40</a>,<a id="xref-ref-41-2" class="xref-bibr" href="#ref-41">41</a></sup>. The ability to overcome IFITM-mediated inhibition of virus production was apparent with all HIV-1, HIV-2 and SIV <em>nef</em> alleles tested. Though the underlying mechanism of ability of Nef to counter IFITMs is unclear, we saw no degradation of IFITMs in the context of viral protein expression. One possible explanation may be re-trafficking, wherein Nef acts as an adaptor protein to direct IFITMs away from their site of action on translation. This fits well with the sensitivity of IFITM-mediated antiviral function to changes in IFITM localization <sup><a id="xref-ref-45-4" class="xref-bibr" href="#ref-45">45</a>,<a id="xref-ref-46-3" class="xref-bibr" href="#ref-46">46</a>,<a id="xref-ref-48-2" class="xref-bibr" href="#ref-48">48</a></sup>, but also fits with the ability of Nef to redirect a multitude of membrane proteins from their site of action <sup><a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>,<a id="xref-ref-39-2" class="xref-bibr" href="#ref-39">39</a>,<a id="xref-ref-59-1" class="xref-bibr" href="#ref-59">59</a>,<a id="xref-ref-60-1" class="xref-bibr" href="#ref-60">60</a></sup>. This may be consistent with our observation that Nef rescues virus particle production in supernatants during IFITM expression, but does not rescue viral protein production.</p><p id="p-50">We also found that, in multiple cycle infections, the benefit of Nef expression was only seen early in culture but was latterly lost. Cell-free infection is prevalent in the early stages of culture, but infection shifts towards a cell-to-cell mode in later stages <sup><a id="xref-ref-42-2" class="xref-bibr" href="#ref-42">42</a></sup>. It has been proposed that this represents a means of escape from immune factors in HIV-1; as the high efficiency, high multiplicity of infection associated with cell-to-cell transmission can overcome restriction <sup><a id="xref-ref-61-1" class="xref-bibr" href="#ref-61">61</a>,<a id="xref-ref-62-1" class="xref-bibr" href="#ref-62">62</a></sup>. For example, with the antiviral restriction factor tetherin, antiviral effect is either severely weakened or absent during cell-to-cell transmission of HIV-1 <sup><a id="xref-ref-31-2" class="xref-bibr" href="#ref-31">31</a>,<a id="xref-ref-63-1" class="xref-bibr" href="#ref-63">63</a>,<a id="xref-ref-64-1" class="xref-bibr" href="#ref-64">64</a></sup>.</p><p id="p-51">Thus we conclude that IFITMs are antiviral factors that can target HIV-1 translation. For retroviruses this seems to be a recurring weak point in replication strategy that the innate immune system has frequently evolved to target. For example, PKR senses viral double stranded RNA and halts translation <sup><a id="xref-ref-65-1" class="xref-bibr" href="#ref-65">65</a></sup>, while Schlaffen 11 inhibits viral protein production by disrupting tRNA synthesis <sup><a id="xref-ref-66-1" class="xref-bibr" href="#ref-66">66</a></sup>, and finally the protein ZAP which induces viral mRNA degradation also stalls viral translation <sup><a id="xref-ref-51-2" class="xref-bibr" href="#ref-51">51</a></sup>.</p><p id="p-52">The model we put forward wherein IFITM expression specifically disrupts viral mRNA translation may be applicable to other targets. Conceptually, other self and non-self RNAs may be affected also. It is then of interest that a recent report found that LINE-1 retrotransposon mobility could be inhibited by IFITM1 expression <sup><a id="xref-ref-67-1" class="xref-bibr" href="#ref-67">67</a></sup>, which for a retrotransposon cannot of course arise from viral entry effects. Future characterization will therefore identify the viral RNA determinant of susceptibility, and the breadth of antiviral and RNA regulatory response driven by IFITM proteins.</p></div><div class="section" id="sec-8"><h2 class="">Methods</h2><div id="sec-9" class="subsection"><h3>Plasmids</h3><p id="p-53">Human pQCXIP IFITM1-3 plasmids bearing an N-terminal FLAG were previously described <sup><a id="xref-ref-58-2" class="xref-bibr" href="#ref-58">58</a></sup>. The viral construct pBR4-3-eGFP-Nef, encoding for wild type HIV-1 NL4-3, pBR4-3-IeGFPΔNef, HIV-1 NA7, HIV-1 NL4-3 plasmids carrying <em>nef</em> alleles of HIV-2 Ren or CBL and SIV AGM or MAC strains - all described in <sup><a id="xref-ref-43-2" class="xref-bibr" href="#ref-43">43</a></sup> - are kind gifts of Professor Frank Kirchhoff (University of Ulm). HIV-2 MCR and MCN plasmids <sup><a id="xref-ref-68-1" class="xref-bibr" href="#ref-68">68</a></sup> are kind gifts of Professor Áine McKnight (Queen Mary University of London). pSIV<sub>agm</sub>Tan-1, pSIV<sub>cpz</sub>Tan1.910 and pSIV<sub>mac</sub>1A11 are from NIH AIDS Reagent Program. Codon-optimized HIV-1 NL4-3 is encoded by pCNC-SYNGP <sup><a id="xref-ref-33-2" class="xref-bibr" href="#ref-33">33</a></sup> (Oxford BioMedica). Plasmids pCTEΔEnvΔRevΔRRE and pCTEΔEnvΔRev <sup><a id="xref-ref-35-2" class="xref-bibr" href="#ref-35">35</a></sup> are kind gifts of Professor Paul Bieniasz (Rockefeller University).</p></div><div id="sec-10" class="subsection"><h3>Antibodies, cells and antiviral compounds</h3><p id="p-54">The following antibodies were used to detect IFITMs: human IFITM1 (clone 5B5E2, Proteintech), IFITM2 (clone 3D5F7, Proteintech) and human IFITM3 (clone EPR5242, Novus Biologicals). Anti-Flag (clone M2, Sigma) was used to detect FLAG-tagged IFITMs, Rev and GFP. Anti-HIV1 Nef (clone 3F2, ThermoFisher), rabbit polyclonal anti-Vpu (Abcam) and rabbit polyclonal anti-HIV1 Gag (Abcam) were used to detect viral proteins. As loading control, β-actin (clone AC74, Sigma) and GAPDH (Abcam) antibodies were used. Secondary antibodies were horseradish peroxidase conjugated goat anti-rabbit/mouse IgG. TZM-bl cells expressing shRNAs targeting IFITMs were previously described <sup><a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a></sup>, as were SupT1 cells inducible for IFITM expression <sup><a id="xref-ref-10-10" class="xref-bibr" href="#ref-10">10</a></sup>. Human Embryonic Kidney (HEK) epithelial 293T cells (HEK293T), C8166 cells, TZM-bl cells, and SupT1 cells were maintained in standard conditions, and were all originally procured from the NIH AIDS Reagents Program. Primary monocytes and CD4<sup>+</sup> T cells were isolated from leukocyte cones (NHS Blood Transfusion service, St. George’s Hospital, London) using the human CD14<sup>+</sup> and CD4<sup>+</sup> T cell isolation kits, respectively, according to manufacturer instruction (Miltenyi Biotec). 0.5×10<sup><a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a></sup>/ml CD14<sup>+</sup> monocytes were differentiated into macrophages with 100ng/ml GMCSF (Peprotech) at 2-3 days interval until day 7. CD4<sup>+</sup> T cells were activated at 1×10<sup><a id="xref-ref-6-3" class="xref-bibr" href="#ref-6">6</a></sup>/ml with T cell activator CD3/CD28 Dynabeads (ThermoFisher), at a bead-to-cell-ratio of 1:1, in complete medium (RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 2mM L-glutamine, 100U/ml streptomycin, 100U/ml penicillin, all from ThermoFisher) and 30U/ml IL-2 (Peprotech) for 48 hours. AMD3100 and Maraviroc were obtained via the NIBSC AIDS Reagent Program.</p></div><div id="sec-11" class="subsection"><h3>Transfections</h3><p id="p-55">HEK293T cells were plated at 2×10<sup>4</sup>/cm<sup>2</sup> in 48-well plates (for measurements of virus production), 6-well plates (for measurements of whole cell viral transcripts by qPCR), 10cm dishes (for virus production, polysome analysis and immunoprecipitation, all from Nunc), 48 hours before transfection. Plasmid DNA (total quantity of 1μg/well in 48-well plates, 3μg/well in 6-well plates and 5μg/well in 10cm dishes) was diluted in OptiMEM (ThermoFisher) at 10% volume of total cell culture medium. Equal quantity of different plasmid DNA was added in co-transfection. Linear polyethylenimine (L-PEI) was added at a w/w ratio of 5:1 into the diluted DNA. The transfection mixture was incubated at room temperature for 10 minutes before added to cells.</p><p id="p-56">For siRNA transfection experiments, HEK293T cells were plated at 1×10<sup>4</sup>/cm<sup>2</sup> 24 hours prior to transfection in 48-well plates. siRNAs at a final concentration of 100nM was added to a total of 100μl OptiMEM, incubated for 5 minutes at room temperature and then 1μl DharmaFECT 1 (Dharmacon) was added to diluted DNA. siRNA-transfection mix was incubated for 20 minutes at room temperature and then added to cells. Expression vectors of IFITMs and HIV-1 proviral DNA were transfected then 48 hours post-transfection.</p><p id="p-57">TZM-bl cells were plated at 6×10<sup>4</sup>/cm<sup>2</sup> in 48-well plates 24 hours before transfection. In a 48-well format, 1μg/well plasmid DNA and 6μl Lipofectamine 2000 (ThermoFisher) were diluted in OptiMEM, incubated for 10 minutes at room temperature and then added to cells. Medium was replaced with medium containing 5μM AMD3100 and 100IU/ml IFN-β (Peprotech) 4 hours post-transfection.</p></div><div id="sec-12" class="subsection"><h3>Intracellular staining and flow cytometry</h3><p id="p-58">IFITM expression in IFNβ-treated human MDMs, CD4<sup>+</sup> T cells, transfected HEK293T cells and doxycycline-treated SupT1 cells was detected by fixing cells in 4% (w/v) paraformaldehyde (Sigma) in PBS for 15 minutes at room temperature, followed by permeabilization in 0.2% (v/v) Triton X-100 (Sigma) for 20 minutes at room temperature. Cells were then blocked in 5% BSA in PBS for 1 hour at room temperature followed by incubation with 1μg/ml IFITM-specific monoclonal antibodies diluted in staining buffer (2% BSA/0.1% Triton X-100/PBS) overnight at 4°C. Cells were washed 3 times with 2% BSA in PBS and labelled with secondary antibodies, human IFITM1, 2 and 3 antibodies were detected by 0.5μg/ml goat anti-mouse IgG2a Alexa Fluor 647, goat anti-mouse IgG1 Alexa Fluor 488 and goat anti-rabbit Alexa Fluor 350, respectively, in staining buffer for 1 hour at room temperature. Labelled cells were washed 3 times in 2% BSA in PBS and analyzed on LSR II flow cytometer (BD). Data was analyzed on FlowJo (BD).</p></div><div id="sec-13" class="subsection"><h3>Infection</h3><p id="p-59">HIV-1 virus was produced from transfected HEK293T cells. SupT1 cells were spinoculated with the indicated concentrations of inoculum for 2 hours at 37 C at 1000x <em>g</em> in 96-well U-bottom plates (Nunc) followed by incubation at 37 C for 1 hour. Infected cells were then washed 3 times with phosphate-buffered saline (PBS, Sigma) and re-suspended in medium with 1μg/ml doxycycline (Sigma) and 5μM AMD3100. C8166 cells were infected with the same protocol without AMD3100. Supernatant was harvested at the indicated time-points after centrifugation at 500x <em>g</em> for 5 minutes at room temperature.</p></div><div id="sec-14" class="subsection"><h3>Transduction and infection of primary human CD4<sup>+</sup> T cells</h3><p id="p-60">In the presence of CD3/CD28 T-cell activator beads, 5×10<sup>5</sup>/ml activated CD4<sup>+</sup> T cells were transduced with IFITM-targeting or scrambled shRNA lentivirus with p24 at 100ng/ml for 2 hours at 1000 x<em>g</em>, 37°C and then for 1 hour incubation. Infected cells were washed three times with PBS, re-suspended in complete medium with 30U/ml IL-2 and then incubated at 37°C for 48 hours. Prior to HIV infection, T cell activator beads were removed from transduced CD4<sup>+</sup> T cells. Transduced CD4<sup>+</sup>T cells were then incubated with medium alone, 5μM Maraviroc or 5μM AMD3100 for 2 hours at 37°C. Untreated cells and drug-treated cells were then infected with 100ng/ml p24 of NL4-3 or 89.6 virus, respectively, at 37°C, 1000 x<em>g</em> for 2 hours and then incubated for 1 hour. Infected cells were then washed three times with PBS and re-suspended in complete medium containing 30U/ml IL-2, 5μM Maraviroc and 5μM AMD3100. Aliquots of infected cells were treated with 0.25% Trypsin/EDTA (ThermoFisher) for 15 minutes at 37°C, washed three times with PBS, fixed in 2% paraformaldehyde, permeabilized in 0.2% Triton X-100/PBS and stained with RD-1 conjugated monoclonal mouse anti-HIV-1-p24 (clone KC57, Beckman Coulter) for flow cytometry analysis of internalized virus. Level of viral output in supernatant was measured by p24 ELISA 72 hours post-infection.</p></div><div id="sec-15" class="subsection"><h3>p24 ELISA</h3><p id="p-61">ELISA plates (Nunc) were pre-coated with 5μg/ml sheep anti-HIV-1 p24 antibody (Aalto Bio Reagents) at 4 C overnight. Supernatant of transfected HEK293T, TZM-bl cells or infected cells was treated with 1% Empigen BB (Sigma) for 30 minutes at 56°C, then plated at 1:10 dilution in Tris-buffered saline (TBS) on anti-p24-coated plates and incubated for 3 hours at room temperature. Alkaline phosphatase-conjugated mouse anti-HIV-1 p24 monoclonal antibody (Aalto Bio Reagents) diluted in 20% sheep serum, 0.05% v/v Tween-20, TBS (all from Sigma) was then added and incubated for 1 hour at room temperature. Plates were washed 4 times with 0.01% v/v Tween-20 in PBS and twice with ELISA Light washing buffer (ThermoFisher). CSPD substrate with Sapphire II enhancer (ThermoFisher) was added and incubated for 30 minutes at room temperature before chemiluminiscence was read by a plate reader.</p></div><div id="sec-16" class="subsection"><h3>Reverse transcriptase (RT) activity and luciferase activity assays</h3><p id="p-62">Colorimetric reverse transcriptase activity assay kit (Roche) was used to determine reverse transcriptase activity of HIV-1, HIV-2 and SIV in supernatants of transfected HEK293T cells. Manufacturer instructions was followed except that supernatant was first treated directly with lysis buffer (50mM Tris pH7.8, 80mM potassium chloride, 2.5mM DTT, 750μM EDTA and 0.5% Triton X-100, all from Sigma) for 30 minutes at room temperature and then incubated in streptavidin-coated microplates for 15 hours at 37 C.</p><p id="p-63">Luciferase activity of infected TZM/bl cells was analyzed with Bright-Glo luciferase activity kit following manufacturer instructions (Promega).</p></div><div id="sec-17" class="subsection"><h3>Polysome profiling</h3><p id="p-64">Polysome analysis was performed with both manual fractionation and RNA analysis <sup><a id="xref-ref-69-1" class="xref-bibr" href="#ref-69">69</a></sup>. Transfected HEK293T cells were incubated with 100μg/ml cycloheximide (Sigma) for 15 minutes for 37°C and then washed with ice-cold PBS with 100μg/ml cycloheximide. Cells were then lysed in polysome buffer, 10mM Tris pH8, 140mM NaCl, 1.5mM MgCl<sub>2</sub>, 0.5% v/v NP40, 100μg/ml cycloheximide, protease inhibitor cocktail (all from Sigma) and 800U/ml RNase OUT (ThermoFisher), for 10 minutes on ice. Cell lysate was centrifuged at 10, 000x <em>g</em> for 1 minute at 4°C and supernatant was then adjusted to 200μg/ml cycloheximide and 700μg/ml heparin (Sigma). Following centrifugation at 12, 000x <em>g</em> for 10 minutes at 4°C, an aliquot of supernatant was taken as input and the rest was layered onto a 10% to 50% sucrose gradient prepared using polysomal buffer. Gradients were then ultracentrifuged at 300,000x <em>g</em> for 16 hours at 4°C (Sorvall). After centrifugation, 20 550μl fractions were collected from the top of the gradients for immunoblotting and quantitative PCR analyses. Level of RNA in fractions was measured by absorbance at 254 nm (Nanodrop) and RNA was precipitated with 5x volume of absolute ethanol (Sigma) overnight at −20°C.</p></div><div id="sec-18" class="subsection"><h3>Quantitative PCR</h3><p id="p-65">Total RNA of transfected HEK293T cells and precipitated RNA from polysome profiling fractions were purified with RNeasy mini kit and on-column DNA digestion with RNase-free DNase kit (both from Qiagen) following manufacturer instructions. 3ng of total RNA per sample was analyzed with Superscript III Platinum One-Step qRT-PCR kit with ROX (for unspliced and multiply spliced viral transcripts, ThermoFisher) or QuantiTect SYBR Green PCR kit (for singly-spliced viral transcript, Qiagen) and ABI 7500 Real Time PCR system (Applied Biosystems). Cycling conditions were 50°C C for 15 minutes, 95°C C for 8 minutes, then cycling of 95°C for 15 s and 60°C for 30 s. Reactions carried out in the absence of reverse transcriptase (Platinum <em>Taq</em> only) confirmed the absence of DNA contamination. The samples were quantified against cloned standards.</p><p id="p-66">Primers used to amplify unspliced (Forward, 5’-CCGTCTGTTGTGTGACTCTGG-3’, reverse, 5’-GAGTCCTGCGTCGAGAGATCT-3’), multiply-spliced (Forward, 5’-CAGACTCATCAAGCTTCTCTATCAA-3’, reverse, 5’-CTATTCCTTCGGGCCTGTC-3’) and singly-spliced (Forward, 5’-TAATCGGCCGAACAGGGACTTGAAAGCGAAAG-3’, reverse, 5’-CCCATCTCCACAAGTGCTGATACTTC-3’) viral transcripts are described in <sup><a id="xref-ref-70-1" class="xref-bibr" href="#ref-70">70</a></sup>, <sup><a id="xref-ref-71-1" class="xref-bibr" href="#ref-71">71</a></sup>, and <sup><a id="xref-ref-72-1" class="xref-bibr" href="#ref-72">72</a></sup>, respectively. Oligonucleotide probes are labelled with 5’-FAM and 3’-TAMRA, (unspliced, 5’-TCTAGCAGTGGCGCCCGAACAGG-3’ and multiply-spliced, 5’-AACCCACCTCCCAATCCCGAGG-3’, all from ThermoFisher). Cellular GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA was additionally amplified as a loading control with primers (Forward, 5’-AGGTCGGAGTCAACGG ATTTGG-3’, reverse, 5’-GATGGCAACAATATCCACTTTACCA-3’) and probe (5’-TCTTATTGGGCGCCTGGTCAC-3’, as described in <sup><a id="xref-ref-71-2" class="xref-bibr" href="#ref-71">71</a></sup>.</p></div><div id="sec-19" class="subsection"><h3>Immunoblotting</h3><p id="p-67">Cells were washed once with PBS and then lyzed in radioimmunoprecipitation buffer (RIPA, containing 20mM Tris pH7.5, 150mM NaCl, 1mM EDTA, 1mM EGTA, 1% NP40, 1% sodium deoxycholate, 250μM sodium pyrophosphate, 1mM β-glycerophosphate, 1mM sodium vanadate and protease inhibitor cocktail, all from Sigma) for 30 minutes at 4°C. Lysate was then centrifuged for 10, 000x <em>g</em> for 10 minutes at 4°C. Protein concentration of supernatant was determined by bicinchoninic acid (BCA) assay (ThermoFisher). 10μg of protein per sample was analyzed by immunoblotting, developed with ECL Prime reagents (GE Healthcare Life Sciences) and captured on CL-XPosure films (ThermoFisher) or ChemiDoc MP system (Bio-Rad). Intensity of immunobands was analyzed by ImageJ (on X-ray films) or ImageLab (Bio-Rad).</p></div><div id="sec-20" class="subsection"><h3>Statistical analysis</h3><p id="p-68">Levels of viral output in p24 ELISA and RT assay were normalized to vector-transfected or scrambled shRNA-transduced control and expressed as the level of virus production unless otherwise indicated. Statistical analysis was performed with Graphpad Prism 5. Data shows mean + standard error of mean from a minimum of 3 independent experiments.</p></div></div><div class="section" id="sec-21"><h2 class="">Author Contributions</h2><p id="p-70">Designed the study: WYL, CL, RDS. Performed the experiments: WYL, RDS. Analyzed the data: WYL, RDS. Wrote the manuscript: WYL, RDS. Contributed reagents: CL.</p></div><div class="section COI-statement" id="sec-22"><h2 class="">Competing Interests</h2><p id="p-71">No competing interests are declared.</p></div><div class="section" id="sec-23"><h2 class="">Supporting Information Figure legends</h2><p id="p-72"><strong>Supporting Fig 1. IFITMs inhibit HIV-1, HIV-2 and SIV viral output.</strong> Levels of virus production of HEK293T cells transfected with 0.5μg expression vectors of IFITMs and 0.5μ<strong>g (A)</strong> HIV-2 strains or <strong>(B)</strong> SIVs (AGM –African Green Monkey, CPZ – Chimpanzee, MAC – Macaque) proviral DNA were measured by RT activity assay and normalized. <strong>(C)</strong> Levels of virus production of HEK293T cells transfected with 0.5μg expression vectors of African Green Monkey IFITM1 and 0.5μg proviral DNA of HIV-1 were measured by p24 ELISA and normalized. Data shows mean+SEM of 3 independent experiments. Differences were analyzed with Student’s t-test and * indicates p&lt;0.05.</p><p id="p-73"><strong>Supporting Fig 2. AMD3100 blocks HIV-1 NL4-3 entry in SupT1 cells.</strong> 1×10<sup>6</sup>/ml SupT1 cells were treated with 5μM AMD3100 or DMSO for 2 hours at 37°C and then left untreated or infected with HIV-1 NL4-3 with p24 concentration of 100ng/ml for 2 hours by spinoculation and 1 hour incubation at 37°C. Cells were then washed 3 times with PBS. Levels of virus production were measured by p24 ELISA 48 hours post-transfection. Mean fluorescence intensity of IFITMs in <strong>(B)</strong> human monocyte-derived macrophages (MDMs, day 7) and <strong>(C)</strong> human CD4<sup>+</sup> T cells treated with indicated concentrations of IFNβ for 24 hours; <strong>(D)</strong> HEK293T cells transfected with 0.5μg IFITM-encoding plasmids and 0.5μg HIV-1 proviral DNA for 48 hours and <strong>(E)</strong> SupT1 cells treated with 1μg/ml doxycycline for 48 hours to induce expression of the indicated IFITMs, was measured by intracellular staining of IFITMs with monoclonal antibodies and flow cytometry. Data shows mean+SEM of 3 independent experiments.</p><p id="p-74"><strong>Supporting Fig 3. Substituting the MPMV CTE for the HIV-1 RRE does not affect IFITM-mediated inhibition of HIV-1 production.</strong> HEK293T cells were transfected with expression vectors for IFITMs and HIV-1 NL4-3 DNA (wild type [<em>i.e.</em> RRE bearing], MPMV CTE only or CTE+RRE). Level of viral production was measured by p24 ELISA 48 hours post-transfection and normalized. Data shows mean+SEM of 3 independent experiments. Differences were analyzed with Student’s t-test and * indicates p&lt;0.05.</p><p id="p-75"><strong>Supporting Fig 4. (A) HIV-1 Nef does not overcome IFITM-mediated inhibition of early viral replication steps.</strong> C8166 CD4<sup>+</sup> T-cells were transduced to constitutively overexpress IFITM1-3. Cells were then infected with the wild type pBR4-3-eGFP-Nef virus or pBR4-3-eGFP-ΔNef virus. Cells were measured for GFP expression 48h post-infection by FACS to determine infection rate. Data shows fold-change in restriction of GFP infection rates during IFITM expression relative to empty vector control cells. <strong>(B)</strong> Levels of p55 and p24 in immunoblotting of <a id="xref-fig-7-13" class="xref-fig" href="#F7">Fig. 7B</a> were quantified by densitometry and normalized to β-actin. Data shows mean + SEM of the ratio of viral proteins to β-actin of 3 independent experiments and differences were assessed by Student’s t-test, * denotes p&lt;0.05. <strong>(C) Increasing Nef levels rescues HIV-1 protein production during IFITM expression.</strong> HEK293T cells were transfected with ΔNef HIV-1 NL4-3 proviral DNA, expression vectors for IFITMs and an increasing proportion of HIV-1 Nef-encoding vector versus empty vector in a fixed total quantity. Levels of viral proteins and IFITM-FLAG expression was analyzed by immunoblotting and densitometry. Data show mean + SEM of 3 independent experiments and differences were assessed by Student’s t-test, * denotes p&lt;0.05.</p></div><div class="section ack" id="ack-1"><h2 class="">Acknowledgements</h2><p id="p-69">We thank Áine McKnight for helpful discussions regarding this work and Greg Towers for useful comments on this manuscript. RDS was supported as a Barts and The London School of Medicine and Dentistry Early Career Research Fellow. We thank Frank Kirchhoff, Paul Bieniasz, and both the NIH and NIBSC AIDS reagent programmes for the provision of reagents.</p></div><div class="section fn-group" id="fn-group-1"><h2>Footnotes</h2><ul><li class="fn" id="fn-1"><p id="p-1">E-mail: <span class="em-link"><span class="em-addr">jason.lee{at}qmul.ac.uk</span></span>, <span class="em-link"><span class="em-addr">chen.liang{at}mcgill.ca</span></span>, <span class="em-link"><span class="em-addr">richard.sloan{at}ed.ac.uk</span></span></p></li></ul></div><div class="section ref-list" id="ref-list-1"><h2 class="">References</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.1" data-doi="10.1101/cshperspect.a006940"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Malim</span>,  <span class="cit-name-given-names">M. H.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Bieniasz</span>,  <span class="cit-name-given-names">P. D.</span></span> <span class="cit-article-title">HIV Restriction Factors and Mechanisms of Evasion</span>. <abbr class="cit-jnl-abbrev">Cold Spring Harb Perspect Med</abbr> <span class="cit-vol">2</span>, <span class="cit-fpage">a006940</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCold%2BSpring%2BHarb%2BPerspect%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1101%252Fcshperspect.a006940%26rft_id%253Dinfo%253Apmid%252F22553496%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTQ6ImNzaHBlcnNwZWN0bWVkIjtzOjU6InJlc2lkIjtzOjExOiIyLzUvYTAwNjk0MCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.2" data-doi="10.1038/ni.3156"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Simon</span>,  <span class="cit-name-given-names">V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bloch</span>,  <span class="cit-name-given-names">N.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Landau</span>,  <span class="cit-name-given-names">N. R.</span></span> <span class="cit-article-title">Intrinsic host restrictions to HIV-1 and mechanisms of viral escape</span>. <abbr class="cit-jnl-abbrev">Nat. Immunol.</abbr> <span class="cit-vol">16</span>, <span class="cit-fpage">546</span>–<span class="cit-lpage">553</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNat.%2BImmunol.%26rft.volume%253D16%26rft.spage%253D546%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fni.3156%26rft_id%253Dinfo%253Apmid%252F25988886%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/ni.3156&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25988886&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.3" data-doi="10.1016/j.cell.2015.10.019"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kluge</span>,  <span class="cit-name-given-names">S. F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sauter</span>,  <span class="cit-name-given-names">D.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Kirchhoff</span>,  <span class="cit-name-given-names">F.</span></span> <span class="cit-article-title">SnapShot: Antiviral Restriction Factors</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-vol">163</span>, <span class="cit-fpage">774</span>–<span class="cit-lpage">774.e1</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%26rft.volume%253D163%26rft.spage%253D774%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2015.10.019%26rft_id%253Dinfo%253Apmid%252F26496613%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.cell.2015.10.019&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26496613&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.4" data-doi="10.1186/1742-4690-8-94"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Liu</span>,  <span class="cit-name-given-names">L.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">A whole genome screen for HIV restriction factors</span>. <abbr class="cit-jnl-abbrev">Retrovirology</abbr> <span class="cit-vol">8</span>, <span class="cit-fpage">94</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DRetrovirology%26rft.aulast%253DLiu%26rft.auinit1%253DL.%26rft.volume%253D8%26rft.spage%253D94%26rft.epage%253D94%26rft.atitle%253DA%2Bwhole%2Bgenome%2Bscreen%2Bfor%2BHIV%2Brestriction%2Bfactors.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1742-4690-8-94%26rft_id%253Dinfo%253Apmid%252F22082156%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1186/1742-4690-8-94&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22082156&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.5" data-doi="10.1038/nature12653"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kane</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">MX2 is an interferon-induced inhibitor of HIV-1 infection</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">502</span>, <span class="cit-fpage">563</span>–<span class="cit-lpage">566</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D502%26rft.spage%253D563%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature12653%26rft_id%253Dinfo%253Apmid%252F24121441%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature12653&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=24121441&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000325988400057&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.6" data-doi="10.1038/nature12542"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Goujon</span>,  <span class="cit-name-given-names">C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">502</span>, <span class="cit-fpage">559</span>–<span class="cit-lpage">562</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D502%26rft.spage%253D559%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature12542%26rft_id%253Dinfo%253Apmid%252F24048477%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature12542&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=24048477&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000325988400056&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.7" data-doi="10.1038/nature15399"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Rosa</span>,  <span class="cit-name-given-names">A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">526</span>, <span class="cit-fpage">212</span>–<span class="cit-lpage">217</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D526%26rft.spage%253D212%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature15399%26rft_id%253Dinfo%253Apmid%252F26416734%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature15399&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26416734&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.8" data-doi="10.1038/nature15400"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Usami</span>,  <span class="cit-name-given-names">Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wu</span>,  <span class="cit-name-given-names">Y.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Göttlinger</span>,  <span class="cit-name-given-names">H. G.</span></span> <span class="cit-article-title">SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">526</span>, <span class="cit-fpage">218</span>–<span class="cit-lpage">223</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D526%26rft.spage%253D218%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature15400%26rft_id%253Dinfo%253Apmid%252F26416733%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature15400&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26416733&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.9" data-doi="10.1016/j.cell.2009.12.017"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Brass</span>,  <span class="cit-name-given-names">A. L.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-vol">139</span>, <span class="cit-fpage">1243</span>–<span class="cit-lpage">1254</span> (<span class="cit-pub-date">2009</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%26rft.stitle%253DCell%26rft.aulast%253DBrass%26rft.auinit1%253DA.%2BL.%26rft.volume%253D139%26rft.issue%253D7%26rft.spage%253D1243%26rft.epage%253D1254%26rft.atitle%253DThe%2BIFITM%2Bproteins%2Bmediate%2Bcellular%2Bresistance%2Bto%2Binfluenza%2BA%2BH1N1%2Bvirus%252C%2BWest%2BNile%2Bvirus%252C%2Band%2Bdengue%2Bvirus.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2009.12.017%26rft_id%253Dinfo%253Apmid%252F20064371%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.cell.2009.12.017&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=20064371&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000273048700013&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.10" data-doi="10.1128/JVI.01531-10"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lu</span>,  <span class="cit-name-given-names">J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The IFITM proteins inhibit HIV-1 infection</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">85</span>, <span class="cit-fpage">2126</span>–<span class="cit-lpage">2137</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01531-10%26rft_id%253Dinfo%253Apmid%252F21177806%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6Ijg1LzUvMjEyNiI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">11.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-201525v2.11" data-doi="10.1038/nature09907"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schoggins</span>,  <span class="cit-name-given-names">J. W.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">A diverse range of gene products are effectors of the type I interferon antiviral response</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">472</span>, <span class="cit-fpage">481</span>–<span class="cit-lpage">485</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DSchoggins%26rft.auinit1%253DJ.%2BW.%26rft.volume%253D472%26rft.issue%253D7344%26rft.spage%253D481%26rft.epage%253D485%26rft.atitle%253DA%2Bdiverse%2Brange%2Bof%2Bgene%2Bproducts%2Bare%2Beffectors%2Bof%2Bthe%2Btype%2BI%2Binterferon%2Bantiviral%2Bresponse.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature09907%26rft_id%253Dinfo%253Apmid%252F21478870%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature09907&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21478870&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000289949600036&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.12" data-doi="10.1016/j.chom.2012.08.012"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wilson</span>,  <span class="cit-name-given-names">S. J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Inhibition of HIV-1 particle assembly by 2’,3“-cyclic-nucleotide 3”-phosphodiesterase</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">12</span>, <span class="cit-fpage">585</span>–<span class="cit-lpage">597</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DCell%2BHost%2BMicrobe%26rft.aulast%253DWilson%26rft.auinit1%253DS.%2BJ.%26rft.volume%253D12%26rft.issue%253D4%26rft.spage%253D585%26rft.epage%253D597%26rft.atitle%253DInhibition%2Bof%2BHIV-1%2BParticle%2BAssembly%2Bby%2B2%2527%252C3%2527-Cyclic-Nucleotide%2B3%2527-Phosphodiesterase.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2012.08.012%26rft_id%253Dinfo%253Apmid%252F23084924%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2012.08.012&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23084924&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000310719700019&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.13"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Bailey</span>,  <span class="cit-name-given-names">C. C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zhong</span>,  <span class="cit-name-given-names">G.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Huang</span>,  <span class="cit-name-given-names">I.-C.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Farzan</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-article-title">IFITM-Family Proteins: The Cell’s First Line of Antiviral Defense</span>. <abbr class="cit-jnl-abbrev">Annual Review of Virology</abbr> <span class="cit-vol">1</span>, <span class="cit-fpage">261</span>–<span class="cit-lpage">283</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAnnual%2BReview%2Bof%2BVirology%26rft.volume%253D1%26rft.spage%253D261%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.14" data-doi="10.1016/j.chom.2014.11.001"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Compton</span>,  <span class="cit-name-given-names">A. A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">16</span>, <span class="cit-fpage">736</span>–<span class="cit-lpage">747</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BHost%2BMicrobe%26rft.volume%253D16%26rft.spage%253D736%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2014.11.001%26rft_id%253Dinfo%253Apmid%252F25464829%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2014.11.001&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25464829&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.15" data-doi="10.1186/s12977-014-0103-y"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Tartour</span>,  <span class="cit-name-given-names">K.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity</span>. <abbr class="cit-jnl-abbrev">Retrovirology</abbr> <span class="cit-vol">11</span>, <span class="cit-fpage">103</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DRetrovirology%26rft.volume%253D11%26rft.spage%253D103%26rft_id%253Dinfo%253Adoi%252F10.1186%252Fs12977-014-0103-y%26rft_id%253Dinfo%253Apmid%252F25422070%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1186/s12977-014-0103-y&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25422070&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.16" data-doi="10.1371/journal.ppat.1006610"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Tartour</span>,  <span class="cit-name-given-names">K.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs</span>. <abbr class="cit-jnl-abbrev">PLoS Pathog</abbr> <span class="cit-vol">13</span>, <span class="cit-fpage">e1006610</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BPathog%26rft.volume%253D13%26rft.spage%253De1006610%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1006610%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.ppat.1006610&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.17" data-doi="10.1016/j.chom.2013.03.006"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Amini-Bavil-Olyaee</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">13</span>, <span class="cit-fpage">452</span>–<span class="cit-lpage">464</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BHost%2BMicrobe%26rft.volume%253D13%26rft.spage%253D452%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2013.03.006%26rft_id%253Dinfo%253Apmid%252F23601107%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2013.03.006&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23601107&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000330850500010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.18" data-doi="10.1016/j.celrep.2015.08.055"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yu</span>,  <span class="cit-name-given-names">J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein</span>. <abbr class="cit-jnl-abbrev">Cell Rep</abbr> <span class="cit-vol">13</span>, <span class="cit-fpage">145</span>–<span class="cit-lpage">156</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BRep%26rft.volume%253D13%26rft.spage%253D145%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.celrep.2015.08.055%26rft_id%253Dinfo%253Apmid%252F26387945%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.celrep.2015.08.055&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26387945&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text" id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.19" data-doi="10.1371/journal.ppat.1001258"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Huang</span>,  <span class="cit-name-given-names">I.-C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus</span>. <abbr class="cit-jnl-abbrev">PLoS Pathog</abbr> <span class="cit-vol">7</span>, <span class="cit-fpage">e1001258</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DPLoS%2BPathog%26rft.aulast%253DHuang%26rft.auinit1%253DI.%2BC.%26rft.volume%253D7%26rft.issue%253D1%26rft.spage%253De1001258%26rft.epage%253De1001258%26rft.atitle%253DDistinct%2Bpatterns%2Bof%2BIFITM-mediated%2Brestriction%2Bof%2Bfiloviruses%252C%2BSARS%2Bcoronavirus%252C%2Band%2Binfluenza%2BA%2Bvirus.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1001258%26rft_id%253Dinfo%253Apmid%252F21253575%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.ppat.1001258&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21253575&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">20.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-201525v2.20" data-doi="10.1002/hep.26066"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wilkins</span>,  <span class="cit-name-given-names">C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">IFITM1 is a tight junction protein that inhibits hepatitis C virus entry</span>. <abbr class="cit-jnl-abbrev">Hepatology</abbr> <span class="cit-vol">57</span>, <span class="cit-fpage">461</span>–<span class="cit-lpage">469</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DHepatology%26rft.volume%253D57%26rft.spage%253D461%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep.26066%26rft_id%253Dinfo%253Apmid%252F22996292%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1002/hep.26066&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22996292&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000315643400007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.21" data-doi="10.1016/j.celrep.2016.05.074"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Savidis</span>,  <span class="cit-name-given-names">G.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The IFITMs Inhibit Zika Virus Replication</span>. <abbr class="cit-jnl-abbrev">Cell Rep</abbr> <span class="cit-vol">15</span>, <span class="cit-fpage">2323</span>–<span class="cit-lpage">2330</span> (<span class="cit-pub-date">2016</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BRep%26rft.volume%253D15%26rft.spage%253D2323%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.celrep.2016.05.074%26rft_id%253Dinfo%253Apmid%252F27268505%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.celrep.2016.05.074&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=27268505&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text" id="ref-22">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.22"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">Y.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">91</span>, <span class="cit-fpage">e02441</span>–<span class="cit-lpage">16</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft.volume%253D91%26rft.spage%253De02441%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">23.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-201525v2.23" data-doi="10.1016/j.chom.2016.08.005"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kane</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Identification of Interferon-Stimulated Genes with Antiretroviral Activity</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">20</span>, <span class="cit-fpage">392</span>–<span class="cit-lpage">405</span> (<span class="cit-pub-date">2016</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BHost%2BMicrobe%26rft.volume%253D20%26rft.spage%253D392%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2016.08.005%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2016.08.005&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.24" data-doi="10.15252/embr.201642771"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Compton</span>,  <span class="cit-name-given-names">A. A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity</span>. <abbr class="cit-jnl-abbrev">EMBO Rep.</abbr> <span class="cit-fpage">e201642771</span>–<span class="cit-lpage">15</span> (<span class="cit-pub-date">2016</span>).<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.15252/embr.201642771</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEMBO%2BRep.%26rft_id%253Dinfo%253Adoi%252F10.15252%252Fembr.201642771%26rft_id%253Dinfo%253Apmid%252F27601221%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NToiZW1ib3IiO3M6NToicmVzaWQiO3M6MTA6IjE3LzExLzE2NTciO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxOC8wNC8xMS8yMDE1MjUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text" id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.25"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ding</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Pan</span>,  <span class="cit-name-given-names">Q.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Liu</span>,  <span class="cit-name-given-names">S.-L.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Liang</span>,  <span class="cit-name-given-names">C.</span></span> <span class="cit-article-title">HIV-1 mutates to evade IFITM1 restriction</span>. <abbr class="cit-jnl-abbrev">Virology</abbr> <span class="cit-vol">454–455</span>, <span class="cit-fpage">11</span>–<span class="cit-lpage">24</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirology%26rft.volume%253D454455%26rft.spage%253D11%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text" id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.26" data-doi="10.1016/j.micinf.2012.12.003"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chutiwitoonchai</span>,  <span class="cit-name-given-names">N.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins</span>. <abbr class="cit-jnl-abbrev">Microbes Infect.</abbr> <span class="cit-vol">15</span>, <span class="cit-fpage">280</span>–<span class="cit-lpage">290</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMicrobes%2BInfect.%26rft.volume%253D15%26rft.spage%253D280%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.micinf.2012.12.003%26rft_id%253Dinfo%253Apmid%252F23376165%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.micinf.2012.12.003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23376165&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000318000200004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text" id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.27" data-doi="10.1016/j.virol.2014.10.015"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Qian</span>,  <span class="cit-name-given-names">J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins</span>. <abbr class="cit-jnl-abbrev">Virology</abbr> <span class="cit-vol">474</span>, <span class="cit-fpage">10</span>–<span class="cit-lpage">18</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirology%26rft.volume%253D474%26rft.spage%253D10%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.virol.2014.10.015%26rft_id%253Dinfo%253Apmid%252F25463599%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.virol.2014.10.015&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25463599&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text" id="ref-28">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.28" data-doi="10.1016/j.chom.2016.08.006"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Foster</span>,  <span class="cit-name-given-names">T. L.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-fpage">1</span>–<span class="cit-lpage">15</span> (<span class="cit-pub-date">2016</span>).<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1016/j.chom.2016.08.006</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BHost%2BMicrobe%26rft.volume%253D20%26rft.spage%253D429%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2016.08.006%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2016.08.006&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text" id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.29"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Maréchal</span>,  <span class="cit-name-given-names">V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Clavel</span>,  <span class="cit-name-given-names">F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Heard</span>,  <span class="cit-name-given-names">J. M.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Schwartz</span>,  <span class="cit-name-given-names">O.</span></span> <span class="cit-article-title">Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">72</span>, <span class="cit-fpage">2208</span>–<span class="cit-lpage">2212</span> (<span class="cit-pub-date">1998</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DMarechal%26rft.auinit1%253DV.%26rft.volume%253D72%26rft.issue%253D3%26rft.spage%253D2208%26rft.epage%253D2212%26rft.atitle%253DCytosolic%2BGag%2Bp24%2Bas%2Ban%2BIndex%2Bof%2BProductive%2BEntry%2Bof%2BHuman%2BImmunodeficiency%2BVirus%2BType%2B1%26rft_id%253Dinfo%253Apmid%252F9499078%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6IjcyLzMvMjIwOCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">30.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-201525v2.30" data-doi="10.1128/JVI.00815-13"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sloan</span>,  <span class="cit-name-given-names">R. D.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">87</span>, <span class="cit-fpage">8110</span>–<span class="cit-lpage">8123</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00815-13%26rft_id%253Dinfo%253Apmid%252F23678185%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4Ny8xNC84MTEwIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTgvMDQvMTEvMjAxNTI1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">31.</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31. in text" id="ref-31">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.31" data-doi="10.1128/JVI.01447-10"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jolly</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Booth</span>,  <span class="cit-name-given-names">N. J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Neil</span>,  <span class="cit-name-given-names">S. J. D.</span></span> <span class="cit-article-title">Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">84</span>, <span class="cit-fpage">12185</span>–<span class="cit-lpage">12199</span> (<span class="cit-pub-date">2010</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01447-10%26rft_id%253Dinfo%253Apmid%252F20861257%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4NC8yMy8xMjE4NSI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">32.</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32. in text" id="ref-32">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.32" data-doi="10.1186/1742-4690-8-99"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">la Vega, de</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion</span>. <abbr class="cit-jnl-abbrev">Retrovirology</abbr> <span class="cit-vol">8</span>, <span class="cit-fpage">99</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DRetrovirology%26rft.aulast%253Dde%2Bla%2BVega%26rft.auinit1%253DM.%26rft.volume%253D8%26rft.spage%253D99%26rft.epage%253D99%26rft.atitle%253DInhibition%2Bof%2BHIV-1%2Bendocytosis%2Ballows%2Blipid%2Bmixing%2Bat%2Bthe%2Bplasma%2Bmembrane%252C%2Bbut%2Bnot%2Bcomplete%2Bfusion.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1742-4690-8-99%26rft_id%253Dinfo%253Apmid%252F22145853%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1186/1742-4690-8-99&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22145853&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">33.</span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33. in text" id="ref-33">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.33" data-doi="10.1038/nbt815"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ikeda</span>,  <span class="cit-name-given-names">Y.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Continuous high-titer HIV-1 vector production</span>. <abbr class="cit-jnl-abbrev">Nat. Biotechnol.</abbr> <span class="cit-vol">21</span>, <span class="cit-fpage">569</span>–<span class="cit-lpage">572</span> (<span class="cit-pub-date">2003</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Bbiotechnology%26rft.stitle%253DNat%2BBiotechnol%26rft.aulast%253DIkeda%26rft.auinit1%253DY.%26rft.volume%253D21%26rft.issue%253D5%26rft.spage%253D569%26rft.epage%253D572%26rft.atitle%253DContinuous%2Bhigh-titer%2BHIV-1%2Bvector%2Bproduction.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnbt815%26rft_id%253Dinfo%253Apmid%252F12679787%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nbt815&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12679787&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000182660300037&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">34.</span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34. in text" id="ref-34">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.34" data-doi="10.1128/JVI.74.10.4839-4852.2000"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kotsopoulou</span>,  <span class="cit-name-given-names">E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kim</span>,  <span class="cit-name-given-names">V. N.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kingsman</span>,  <span class="cit-name-given-names">A. J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kingsman</span>,  <span class="cit-name-given-names">S. M.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Mitrophanous</span>,  <span class="cit-name-given-names">K. A.</span></span> <span class="cit-article-title">A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">74</span>, <span class="cit-fpage">4839</span>–<span class="cit-lpage">4852</span> (<span class="cit-pub-date">2000</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DKotsopoulou%26rft.auinit1%253DE.%26rft.volume%253D74%26rft.issue%253D10%26rft.spage%253D4839%26rft.epage%253D4852%26rft.atitle%253DA%2BRev-Independent%2BHuman%2BImmunodeficiency%2BVirus%2BType%2B1%2B%2528HIV-1%2529-Based%2BVector%2BThat%2BExploits%2Ba%2BCodon-Optimized%2BHIV-1%2Bgag-pol%2BGene%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.74.10.4839-4852.2000%26rft_id%253Dinfo%253Apmid%252F10775623%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI3NC8xMC80ODM5IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTgvMDQvMTEvMjAxNTI1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">35.</span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35. in text" id="ref-35">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.35" data-doi="10.1016/j.cell.2014.09.057"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kutluay</span>,  <span class="cit-name-given-names">S. B.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-vol">159</span>, <span class="cit-fpage">1096</span>–<span class="cit-lpage">1109</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%26rft.volume%253D159%26rft.spage%253D1096%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2014.09.057%26rft_id%253Dinfo%253Apmid%252F25416948%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.cell.2014.09.057&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25416948&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000345506300021&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">36.</span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36. in text" id="ref-36">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.36" data-doi="10.1093/emboj/16.24.7500"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Pasquinelli</span>,  <span class="cit-name-given-names">A. E.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway</span>. <abbr class="cit-jnl-abbrev">EMBO J.</abbr> <span class="cit-vol">16</span>, <span class="cit-fpage">7500</span>–<span class="cit-lpage">7510</span> (<span class="cit-pub-date">1997</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BEMBO%2BJournal%26rft.stitle%253DEMBO%2BJ.%26rft.aulast%253DPasquinelli%26rft.auinit1%253DA.%2BE.%26rft.volume%253D16%26rft.issue%253D24%26rft.spage%253D7500%26rft.epage%253D7510%26rft.atitle%253DThe%2Bconstitutive%2Btransport%2Belement%2B%2528CTE%2529%2Bof%2BMason-Pfizer%2Bmonkey%2Bvirus%2B%2528MPMV%2529%2Baccesses%2Ba%2Bcellular%2BmRNA%2Bexport%2Bpathway%26rft_id%253Dinfo%253Adoi%252F10.1093%252Femboj%252F16.24.7500%26rft_id%253Dinfo%253Apmid%252F9405378%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiZW1ib2pubCI7czo1OiJyZXNpZCI7czoxMDoiMTYvMjQvNzUwMCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">37.</span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37. in text" id="ref-37">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.37" data-doi="10.1016/j.chom.2009.05.008"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhang</span>,  <span class="cit-name-given-names">F.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Nef proteins from simian immunodeficiency viruses are tetherin antagonists</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">6</span>, <span class="cit-fpage">54</span>–<span class="cit-lpage">67</span> (<span class="cit-pub-date">2009</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DCell%2BHost%2BMicrobe%26rft.aulast%253DZhang%26rft.auinit1%253DF.%26rft.volume%253D6%26rft.issue%253D1%26rft.spage%253D54%26rft.epage%253D67%26rft.atitle%253DNef%2Bproteins%2Bfrom%2Bsimian%2Bimmunodeficiency%2Bviruses%2Bare%2Btetherin%2Bantagonists.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2009.05.008%26rft_id%253Dinfo%253Apmid%252F19501037%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2009.05.008&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19501037&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000268556000008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">38.</span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38. in text" id="ref-38">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.38" data-doi="10.1016/j.chom.2015.09.003"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Matheson</span>,  <span class="cit-name-given-names">N. J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">18</span>, <span class="cit-fpage">409</span>–<span class="cit-lpage">423</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BHost%2BMicrobe%26rft.volume%253D18%26rft.spage%253D409%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2015.09.003%26rft_id%253Dinfo%253Apmid%252F26439863%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2015.09.003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26439863&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">39.</span><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39. in text" id="ref-39">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.39" data-doi="10.1128/JVI.02333-14"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Haller</span>,  <span class="cit-name-given-names">C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">88</span>, <span class="cit-fpage">14241</span>–<span class="cit-lpage">14257</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.02333-14%26rft_id%253Dinfo%253Apmid%252F25275127%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4OC8yNC8xNDI0MSI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">40.</span><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40. in text" id="ref-40">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.40" data-doi="10.1128/JVI.75.14.6601-6608.2001"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Fackler</span>,  <span class="cit-name-given-names">O. T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">d’Aloja</span>,  <span class="cit-name-given-names">P.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baur</span>,  <span class="cit-name-given-names">A. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Federico</span>,  <span class="cit-name-given-names">M.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Peterlin</span>,  <span class="cit-name-given-names">B. M.</span></span> <span class="cit-article-title">Nef from Human Immunodeficiency Virus Type 1F12 Inhibits Viral Production and Infectivity</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">75</span>, <span class="cit-fpage">6601</span>–<span class="cit-lpage">6608</span> (<span class="cit-pub-date">2001</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DFackler%26rft.auinit1%253DO.%2BT.%26rft.volume%253D75%26rft.issue%253D14%26rft.spage%253D6601%26rft.epage%253D6608%26rft.atitle%253DNef%2Bfrom%2BHuman%2BImmunodeficiency%2BVirus%2BType%2B1F12%2BInhibits%2BViral%2BProduction%2Band%2BInfectivity%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.75.14.6601-6608.2001%26rft_id%253Dinfo%253Apmid%252F11413327%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI3NS8xNC82NjAxIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTgvMDQvMTEvMjAxNTI1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">41.</span><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference 41. in text" id="ref-41">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.41" data-doi="10.1006/viro.1999.0053"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Collette</span>,  <span class="cit-name-given-names">Y.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Olive</span>,  <span class="cit-name-given-names">D.</span></span> <span class="cit-article-title">The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle</span>. <abbr class="cit-jnl-abbrev">Virology</abbr> <span class="cit-vol">265</span>, <span class="cit-fpage">173</span>–<span class="cit-lpage">177</span> (<span class="cit-pub-date">1999</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirology%26rft.stitle%253DVirology%26rft.aulast%253DCollette%26rft.auinit1%253DY.%26rft.volume%253D265%26rft.issue%253D2%26rft.spage%253D173%26rft.epage%253D177%26rft.atitle%253DThe%2Bprimate%2Blentivirus-encoded%2BNef%2Bprotein%2Bcan%2Bregulate%2Bseveral%2Bsteps%2Bof%2Bthe%2Bviral%2Breplication%2Bcycle.%26rft_id%253Dinfo%253Adoi%252F10.1006%252Fviro.1999.0053%26rft_id%253Dinfo%253Apmid%252F10600589%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1006/viro.1999.0053&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=10600589&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">42.</span><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference 42. in text" id="ref-42">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.42" data-doi="10.1128/JVI.74.23.10882-10891.2000"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Gummuluru</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kinsey</span>,  <span class="cit-name-given-names">C. M.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Emerman</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-article-title">An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">74</span>, <span class="cit-fpage">10882</span>–<span class="cit-lpage">10891</span> (<span class="cit-pub-date">2000</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DGummuluru%26rft.auinit1%253DS.%26rft.volume%253D74%26rft.issue%253D23%26rft.spage%253D10882%26rft.epage%253D10891%26rft.atitle%253DAn%2BIn%2BVitro%2BRapid-Turnover%2BAssay%2Bfor%2BHuman%2BImmunodeficiency%2BVirus%2BType%2B1%2BReplication%2BSelects%2Bfor%2BCell-to-Cell%2BSpread%2Bof%2BVirus%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.74.23.10882-10891.2000%26rft_id%253Dinfo%253Apmid%252F11069982%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI3NC8yMy8xMDg4MiI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">43.</span><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference 43. in text" id="ref-43">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.43" data-doi="10.1016/j.cell.2006.04.033"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schindler</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-vol">125</span>, <span class="cit-fpage">1055</span>–<span class="cit-lpage">1067</span> (<span class="cit-pub-date">2006</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%26rft.stitle%253DCell%26rft.aulast%253DSchindler%26rft.auinit1%253DM.%26rft.volume%253D125%26rft.issue%253D6%26rft.spage%253D1055%26rft.epage%253D1067%26rft.atitle%253DNef-mediated%2Bsuppression%2Bof%2BT%2Bcell%2Bactivation%2Bwas%2Blost%2Bin%2Ba%2Blentiviral%2Blineage%2Bthat%2Bgave%2Brise%2Bto%2BHIV-1.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2006.04.033%26rft_id%253Dinfo%253Apmid%252F16777597%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.cell.2006.04.033&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=16777597&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000238602700012&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">44.</span><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference 44. in text" id="ref-44">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.44" data-doi="10.1186/1742-4690-9-55"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lim</span>,  <span class="cit-name-given-names">E. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wu</span>,  <span class="cit-name-given-names">L. I.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Malik</span>,  <span class="cit-name-given-names">H. S.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Emerman</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-article-title">The function and evolution of the restriction factor Viperin in primates was not driven by lentiviruses</span>. <abbr class="cit-jnl-abbrev">Retrovirology</abbr> <span class="cit-vol">9</span>, <span class="cit-fpage">55</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DRetrovirology%26rft.aulast%253DLim%26rft.auinit1%253DE.%2BS.%26rft.volume%253D9%26rft.spage%253D55%26rft.epage%253D55%26rft.atitle%253DThe%2Bfunction%2Band%2Bevolution%2Bof%2Bthe%2Brestriction%2Bfactor%2BViperin%2Bin%2Bprimates%2Bwas%2Bnot%2Bdriven%2Bby%2Blentiviruses.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1742-4690-9-55%26rft_id%253Dinfo%253Apmid%252F22734835%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1186/1742-4690-9-55&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22734835&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">45.</span><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference 45. in text" id="ref-45">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.45" data-doi="10.1074/jbc.M112.362095"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yount</span>,  <span class="cit-name-given-names">J. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Karssemeijer</span>,  <span class="cit-name-given-names">R. A.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Hang</span>,  <span class="cit-name-given-names">H. C.</span></span> <span class="cit-article-title">S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus</span>. <abbr class="cit-jnl-abbrev">J. Biol. Chem.</abbr> <span class="cit-vol">287</span>, <span class="cit-fpage">19631</span>–<span class="cit-lpage">19641</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BBiol.%2BChem.%26rft_id%253Dinfo%253Adoi%252F10.1074%252Fjbc.M112.362095%26rft_id%253Dinfo%253Apmid%252F22511783%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamJjIjtzOjU6InJlc2lkIjtzOjEyOiIyODcvMjMvMTk2MzEiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxOC8wNC8xMS8yMDE1MjUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">46.</span><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference 46. in text" id="ref-46">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.46" data-doi="10.1128/JVI.01828-12"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jia</span>,  <span class="cit-name-given-names">R.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">86</span>, <span class="cit-fpage">13697</span>–<span class="cit-lpage">13707</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01828-12%26rft_id%253Dinfo%253Apmid%252F23055554%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4Ni8yNC8xMzY5NyI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">47.</span><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference 47. in text" id="ref-47">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.47" data-doi="10.1371/journal.pone.0118794"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jia</span>,  <span class="cit-name-given-names">R.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The C-Terminal Sequence of IFITM1 Regulates Its Anti-HIV-1 Activity</span>. <abbr class="cit-jnl-abbrev">PLoS ONE</abbr> <span class="cit-vol">10</span>, <span class="cit-fpage">e0118794</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BONE%26rft.volume%253D10%26rft.spage%253De0118794%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0118794%26rft_id%253Dinfo%253Apmid%252F25738301%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.pone.0118794&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25738301&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">48.</span><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference 48. in text" id="ref-48">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.48" data-doi="10.1128/JVI.00621-13"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hach</span>,  <span class="cit-name-given-names">J. C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">McMichael</span>,  <span class="cit-name-given-names">T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chesarino</span>,  <span class="cit-name-given-names">N. M.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Yount</span>,  <span class="cit-name-given-names">J. S.</span></span> <span class="cit-article-title">Palmitoylation on conserved and non-conserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> (<span class="cit-pub-date">2013</span>).<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1128/JVI.00621-13</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00621-13%26rft_id%253Dinfo%253Apmid%252F23804635%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4Ny8xNy85OTIzIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTgvMDQvMTEvMjAxNTI1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">49.</span><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference 49. in text" id="ref-49">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.49" data-doi="10.1016/j.cell.2005.07.012"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Coller</span>,  <span class="cit-name-given-names">J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Parker</span>,  <span class="cit-name-given-names">R.</span></span> <span class="cit-article-title">General Translational Repression by Activators of mRNA Decapping</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-vol">122</span>, <span class="cit-fpage">875</span>–<span class="cit-lpage">886</span> (<span class="cit-pub-date">2005</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%26rft.stitle%253DCell%26rft.aulast%253DColler%26rft.auinit1%253DJ.%26rft.volume%253D122%26rft.issue%253D6%26rft.spage%253D875%26rft.epage%253D886%26rft.atitle%253DGeneral%2Btranslational%2Brepression%2Bby%2Bactivators%2Bof%2BmRNA%2Bdecapping.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2005.07.012%26rft_id%253Dinfo%253Apmid%252F16179257%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.cell.2005.07.012&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=16179257&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000232130200012&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">50.</span><a class="rev-xref-ref" href="#xref-ref-50-1" title="View reference 50. in text" id="ref-50">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.50" data-doi="10.1126/science.1074276"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Gao</span>,  <span class="cit-name-given-names">G.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Guo</span>,  <span class="cit-name-given-names">X.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Goff</span>,  <span class="cit-name-given-names">S. P.</span></span> <span class="cit-article-title">Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein</span>. <abbr class="cit-jnl-abbrev">Science</abbr> <span class="cit-vol">297</span>, <span class="cit-fpage">1703</span>–<span class="cit-lpage">1706</span> (<span class="cit-pub-date">2002</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DScience%26rft.stitle%253DScience%26rft.aulast%253DGao%26rft.auinit1%253DG.%26rft.volume%253D297%26rft.issue%253D5587%26rft.spage%253D1703%26rft.epage%253D1706%26rft.atitle%253DInhibition%2Bof%2BRetroviral%2BRNA%2BProduction%2Bby%2BZAP%252C%2Ba%2BCCCH-Type%2BZinc%2BFinger%2BProtein%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.1074276%26rft_id%253Dinfo%253Apmid%252F12215647%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEzOiIyOTcvNTU4Ny8xNzAzIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTgvMDQvMTEvMjAxNTI1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">51.</span><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference 51. in text" id="ref-51">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.51" data-doi="10.1038/emboj.2012.271"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhu</span>,  <span class="cit-name-given-names">Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">X.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Goff</span>,  <span class="cit-name-given-names">S. P.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Gao</span>,  <span class="cit-name-given-names">G.</span></span> <span class="cit-article-title">Translational repression precedes and is required for ZAP-mediated mRNA decay</span>. <abbr class="cit-jnl-abbrev">EMBO J.</abbr> <span class="cit-vol">31</span>, <span class="cit-fpage">4236</span>–<span class="cit-lpage">4246</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEMBO%2BJ.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Femboj.2012.271%26rft_id%253Dinfo%253Apmid%252F23023399%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiZW1ib2pubCI7czo1OiJyZXNpZCI7czoxMDoiMzEvMjEvNDIzNiI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">52.</span><a class="rev-xref-ref" href="#xref-ref-52-1" title="View reference 52. in text" id="ref-52">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.52" data-doi="10.1073/pnas.1515387112"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Shin</span>,  <span class="cit-name-given-names">Y. C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bischof</span>,  <span class="cit-name-given-names">G. F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lauer</span>,  <span class="cit-name-given-names">W. A.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Desrosiers</span>,  <span class="cit-name-given-names">R. C.</span></span> <span class="cit-article-title">Importance of codon usage for the temporal regulation of viral gene expression</span>. <abbr class="cit-jnl-abbrev">Proc. Natl. Acad. Sci. U.S.A.</abbr> <span class="cit-vol">112</span>, <span class="cit-fpage">14030</span>–<span class="cit-lpage">14035</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc.%2BNatl.%2BAcad.%2BSci.%2BU.S.A.%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.1515387112%26rft_id%253Dinfo%253Apmid%252F26504241%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMjoiMTEyLzQ1LzE0MDMwIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTgvMDQvMTEvMjAxNTI1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">53.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-201525v2.53" data-doi="10.1016/0092-8674(89)90602-8"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chang</span>,  <span class="cit-name-given-names">D. D.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Sharp</span>,  <span class="cit-name-given-names">P. A.</span></span> <span class="cit-article-title">Regulation by HIV Rev depends upon recognition of splice sites</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-vol">59</span>, <span class="cit-fpage">789</span>–<span class="cit-lpage">795</span> (<span class="cit-pub-date">1989</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%26rft.stitle%253DCell%26rft.aulast%253DChang%26rft.auinit1%253DD.%2BD.%26rft.volume%253D59%26rft.issue%253D5%26rft.spage%253D789%26rft.epage%253D795%26rft.atitle%253DRegulation%2Bby%2BHIV%2BRev%2Bdepends%2Bupon%2Brecognition%2Bof%2Bsplice%2Bsites.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0092-8674%252889%252990602-8%26rft_id%253Dinfo%253Apmid%252F2686839%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/0092-8674(89)90602-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=2686839&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1989CC79800004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">54.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-201525v2.54"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Grantham</span>,  <span class="cit-name-given-names">P.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Perrin</span>,  <span class="cit-name-given-names">P.</span></span> <span class="cit-article-title">AIDS virus and HTLV-I differ in codon choices</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">319</span>, <span class="cit-fpage">727</span>–<span class="cit-lpage">728</span> (<span class="cit-pub-date">1986</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.volume%253D319%26rft.issue%253D6056%26rft.spage%253D727%26rft.atitle%253DIce%2Bshelf%2Bcreep%2Brates%2Band%2Bthe%2Bflow%2Blaw%2Bof%2Bice%253B%2Bdiscussion%26rft_id%253Dinfo%253Apmid%252F3005869%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=1986049806&amp;link_type=GEOREF" class="cit-ref-sprinkles cit-ref-sprinkles-georef"><span>GeoRef</span></a><a href="/lookup/external-ref?access_num=3005869&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1986A232100038&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">55.</span><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference 55. in text" id="ref-55">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.55"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kypr</span>,  <span class="cit-name-given-names">J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Mrázek</span>,  <span class="cit-name-given-names">J.</span></span> <span class="cit-article-title">Unusual codon usage of HIV</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">327</span>, <span class="cit-fpage">20</span>–<span class="cit-lpage">20</span> (<span class="cit-pub-date">1987</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DKypr%26rft.auinit1%253DJ.%26rft.volume%253D327%26rft.issue%253D6117%26rft.spage%253D20%26rft.epage%253D20%26rft.atitle%253DUnusual%2Bcodon%2Busage%2Bof%2BHIV.%26rft_id%253Dinfo%253Apmid%252F3646480%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=3646480&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1987H172600029&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">56.</span><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference 56. in text" id="ref-56">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.56" data-doi="10.1038/nature24039"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Takata</span>,  <span class="cit-name-given-names">M. A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">CG dinucleotide suppression enables antiviral defence targeting non-self RNA</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">550</span>, <span class="cit-fpage">124</span>–<span class="cit-lpage">127</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D550%26rft.spage%253D124%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature24039%26rft_id%253Dinfo%253Apmid%252F28953888%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature24039&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=28953888&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">57.</span><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference 57. in text" id="ref-57">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.57"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Reid</span>,  <span class="cit-name-given-names">D. W.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Nicchitta</span>,  <span class="cit-name-given-names">C. V.</span></span> <span class="cit-article-title">Diversity and selectivity in mRNA translation on the endoplasmic reticulum</span>. <abbr class="cit-jnl-abbrev">Nature Publishing Group</abbr> <span class="cit-vol">16</span>, <span class="cit-fpage">221</span>–<span class="cit-lpage">231</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2BPublishing%2BGroup%26rft.volume%253D16%26rft.spage%253D221%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">58.</span><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference 58. in text" id="ref-58">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.58" data-doi="10.1371/journal.ppat.1003124"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Li</span>,  <span class="cit-name-given-names">K.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">IFITM Proteins Restrict Viral Membrane Hemifusion</span>. <abbr class="cit-jnl-abbrev">PLoS Pathog</abbr> <span class="cit-vol">9</span>, <span class="cit-fpage">e1003124</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BPathog%26rft.volume%253D9%26rft.spage%253De1003124%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1003124%26rft_id%253Dinfo%253Apmid%252F23358889%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.ppat.1003124&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23358889&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">59.</span><a class="rev-xref-ref" href="#xref-ref-59-1" title="View reference 59. in text" id="ref-59">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.59" data-doi="10.1038/34929"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Collins</span>,  <span class="cit-name-given-names">K. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chen</span>,  <span class="cit-name-given-names">B. K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kalams</span>,  <span class="cit-name-given-names">S. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Walker</span>,  <span class="cit-name-given-names">B. D.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Baltimore</span>,  <span class="cit-name-given-names">D.</span></span> <span class="cit-article-title">HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">391</span>, <span class="cit-fpage">397</span>–<span class="cit-lpage">401</span> (<span class="cit-pub-date">1998</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DCollins%26rft.auinit1%253DK.%2BL.%26rft.volume%253D391%26rft.issue%253D6665%26rft.spage%253D397%26rft.epage%253D401%26rft.atitle%253DHIV-1%2BNef%2Bprotein%2Bprotects%2Binfected%2Bprimary%2Bcells%2Bagainst%2Bkilling%2Bby%2Bcytotoxic%2BT%2Blymphocytes.%26rft_id%253Dinfo%253Adoi%252F10.1038%252F34929%26rft_id%253Dinfo%253Apmid%252F9450757%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/34929&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9450757&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000071604200057&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">60.</span><a class="rev-xref-ref" href="#xref-ref-60-1" title="View reference 60. in text" id="ref-60">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.60" data-doi="10.1038/nm0396-338"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schwartz</span>,  <span class="cit-name-given-names">O.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Maréchal</span>,  <span class="cit-name-given-names">V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Le Gall</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lemonnier</span>,  <span class="cit-name-given-names">F.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Heard</span>,  <span class="cit-name-given-names">J. M.</span></span> <span class="cit-article-title">Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein</span>. <abbr class="cit-jnl-abbrev">Nat. Med.</abbr> <span class="cit-vol">2</span>, <span class="cit-fpage">338</span>–<span class="cit-lpage">342</span> (<span class="cit-pub-date">1996</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Bmedicine%26rft.stitle%253DNat%2BMed%26rft.aulast%253DSchwartz%26rft.auinit1%253DO.%26rft.volume%253D2%26rft.issue%253D3%26rft.spage%253D338%26rft.epage%253D342%26rft.atitle%253DEndocytosis%2Bof%2Bmajor%2Bhistocompatibility%2Bcomplex%2Bclass%2BI%2Bmolecules%2Bis%2Binduced%2Bby%2Bthe%2BHIV-1%2BNef%2Bprotein.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnm0396-338%26rft_id%253Dinfo%253Apmid%252F8612235%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nm0396-338&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=8612235&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1996TY64000045&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">61.</span><a class="rev-xref-ref" href="#xref-ref-61-1" title="View reference 61. in text" id="ref-61">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.61" data-doi="10.1128/JVI.01235-09"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Vendrame</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sourisseau</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Perrin</span>,  <span class="cit-name-given-names">V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Schwartz</span>,  <span class="cit-name-given-names">O.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Mammano</span>,  <span class="cit-name-given-names">F.</span></span> <span class="cit-article-title">Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">83</span>, <span class="cit-fpage">10527</span>–<span class="cit-lpage">10537</span> (<span class="cit-pub-date">2009</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01235-09%26rft_id%253Dinfo%253Apmid%252F19706714%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4My8yMC8xMDUyNyI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">62.</span><a class="rev-xref-ref" href="#xref-ref-62-1" title="View reference 62. in text" id="ref-62">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.62" data-doi="10.1016/j.virol.2010.12.031"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jolly</span>,  <span class="cit-name-given-names">C.</span></span> <span class="cit-article-title">Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors</span>. <abbr class="cit-jnl-abbrev">Virology</abbr> <span class="cit-vol">411</span>, <span class="cit-fpage">251</span>–<span class="cit-lpage">259</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirology%26rft.volume%253D411%26rft.spage%253D251%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.virol.2010.12.031%26rft_id%253Dinfo%253Apmid%252F21247613%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.virol.2010.12.031&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21247613&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">63.</span><a class="rev-xref-ref" href="#xref-ref-63-1" title="View reference 63. in text" id="ref-63">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.63" data-doi="10.1186/1742-4690-7-115"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kuhl</span>,  <span class="cit-name-given-names">B. D.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Tetherin restricts direct cell-to-cell infection of HIV-1</span>. <abbr class="cit-jnl-abbrev">Retrovirology</abbr> <span class="cit-vol">7</span>, <span class="cit-fpage">115</span> (<span class="cit-pub-date">2010</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DRetrovirology%26rft.aulast%253DKuhl%26rft.auinit1%253DB.%2BD.%26rft.volume%253D7%26rft.spage%253D115%26rft.epage%253D115%26rft.atitle%253DTetherin%2Brestricts%2Bdirect%2Bcell-to-cell%2Binfection%2Bof%2BHIV-1.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1742-4690-7-115%26rft_id%253Dinfo%253Apmid%252F21184674%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1186/1742-4690-7-115&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21184674&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">64.</span><a class="rev-xref-ref" href="#xref-ref-64-1" title="View reference 64. in text" id="ref-64">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.64" data-doi="10.1371/journal.ppat.1000955"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Casartelli</span>,  <span class="cit-name-given-names">N.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Tetherin restricts productive HIV-1 cell-to-cell transmission</span>. <abbr class="cit-jnl-abbrev">PLoS Pathog</abbr> <span class="cit-vol">6</span>, <span class="cit-fpage">e1000955</span> (<span class="cit-pub-date">2010</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DPLoS%2BPathog%26rft.aulast%253DCasartelli%26rft.auinit1%253DN.%26rft.volume%253D6%26rft.issue%253D6%26rft.spage%253De1000955%26rft.epage%253De1000955%26rft.atitle%253DTetherin%2Brestricts%2Bproductive%2BHIV-1%2Bcell-to-cell%2Btransmission.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1000955%26rft_id%253Dinfo%253Apmid%252F20585562%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.ppat.1000955&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=20585562&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">65.</span><a class="rev-xref-ref" href="#xref-ref-65-1" title="View reference 65. in text" id="ref-65">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.65" data-doi="10.1073/pnas.91.11.4713"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Park</span>,  <span class="cit-name-given-names">H.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci USA</abbr> <span class="cit-vol">91</span>, <span class="cit-fpage">4713</span>–<span class="cit-lpage">4717</span> (<span class="cit-pub-date">1994</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPNAS%26rft.stitle%253DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26rft.aulast%253DPark%26rft.auinit1%253DH.%26rft.volume%253D91%26rft.issue%253D11%26rft.spage%253D4713%26rft.epage%253D4717%26rft.atitle%253DTAR%2BRNA-binding%2Bprotein%2Bis%2Ban%2Binhibitor%2Bof%2Bthe%2Binterferon-induced%2Bprotein%2Bkinase%2BPKR.%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.91.11.4713%26rft_id%253Dinfo%253Apmid%252F7515177%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMDoiOTEvMTEvNDcxMyI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">66.</span><a class="rev-xref-ref" href="#xref-ref-66-1" title="View reference 66. in text" id="ref-66">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.66" data-doi="10.1038/nature11433"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Li</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">491</span>, <span class="cit-fpage">125</span>–<span class="cit-lpage">128</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DLi%26rft.auinit1%253DM.%26rft.volume%253D491%26rft.issue%253D7422%26rft.spage%253D125%26rft.epage%253D128%26rft.atitle%253DCodon-usage-based%2Binhibition%2Bof%2BHIV%2Bprotein%2Bsynthesis%2Bby%2Bhuman%2Bschlafen%2B11.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature11433%26rft_id%253Dinfo%253Apmid%252F23000900%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature11433&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23000900&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000310434500043&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">67.</span><a class="rev-xref-ref" href="#xref-ref-67-1" title="View reference 67. in text" id="ref-67">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.67" data-doi="10.1371/journal.pgen.1005252"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Goodier</span>,  <span class="cit-name-given-names">J. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Pereira</span>,  <span class="cit-name-given-names">G. C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cheung</span>,  <span class="cit-name-given-names">L. E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rose</span>,  <span class="cit-name-given-names">R. J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Kazazian</span>,  <span class="cit-name-given-names">H. H.</span></span> <span class="cit-article-title">The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition</span>. <abbr class="cit-jnl-abbrev">PLoS Genet.</abbr> <span class="cit-vol">11</span>, <span class="cit-fpage">e1005252</span>–<span class="cit-lpage">32</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BGenet.%26rft.volume%253D11%26rft.spage%253De1005252%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pgen.1005252%26rft_id%253Dinfo%253Apmid%252F26001115%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.pgen.1005252&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26001115&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">68.</span><a class="rev-xref-ref" href="#xref-ref-68-1" title="View reference 68. in text" id="ref-68">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.68" data-doi="10.1128/JVI.78.4.2006-2016.2004"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schmitz</span>,  <span class="cit-name-given-names">C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Lv2, a novel postentry restriction, is mediated by both capsid and envelope</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">78</span>, <span class="cit-fpage">2006</span>–<span class="cit-lpage">2016</span> (<span class="cit-pub-date">2004</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DSchmitz%26rft.auinit1%253DC.%26rft.volume%253D78%26rft.issue%253D4%26rft.spage%253D2006%26rft.epage%253D2016%26rft.atitle%253DLv2%252C%2Ba%2BNovel%2BPostentry%2BRestriction%252C%2BIs%2BMediated%2Bby%2Bboth%2BCapsid%2Band%2BEnvelope%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.78.4.2006-2016.2004%26rft_id%253Dinfo%253Apmid%252F14747565%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6Ijc4LzQvMjAwNiI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">69.</span><a class="rev-xref-ref" href="#xref-ref-69-1" title="View reference 69. in text" id="ref-69">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.69"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ogunkolade</span>,  <span class="cit-name-given-names">B. W.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">BORIS/CTCFL is an RNA-binding protein that associates with polysomes</span>. <abbr class="cit-jnl-abbrev">BMC Cell Biol.</abbr> <span class="cit-vol">14</span>, <span class="cit-fpage">52</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBMC%2BCell%2BBiol.%26rft.volume%253D14%26rft.spage%253D52%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">70.</span><a class="rev-xref-ref" href="#xref-ref-70-1" title="View reference 70. in text" id="ref-70">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.70" data-doi="10.1007/s11262-005-5851-2"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yamamoto</span>,  <span class="cit-name-given-names">N.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction</span>. <abbr class="cit-jnl-abbrev">Virus Genes</abbr> <span class="cit-vol">32</span>, <span class="cit-fpage">105</span>–<span class="cit-lpage">113</span> (<span class="cit-pub-date">2006</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirus%2Bgenes%26rft.stitle%253DVirus%2BGenes%26rft.aulast%253DYamamoto%26rft.auinit1%253DN.%26rft.volume%253D32%26rft.issue%253D1%26rft.spage%253D105%26rft.epage%253D113%26rft.atitle%253DAnalysis%2Bof%2Bhuman%2Bimmunodeficiency%2Bvirus%2Btype%2B1%2Bintegration%2Bby%2Busing%2Ba%2Bspecific%252C%2Bsensitive%2Band%2Bquantitative%2Bassay%2Bbased%2Bon%2Breal-time%2Bpolymerase%2Bchain%2Breaction.%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs11262-005-5851-2%26rft_id%253Dinfo%253Apmid%252F16525741%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1007/s11262-005-5851-2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=16525741&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2018%2F04%2F11%2F201525.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000235905100013&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">71.</span><a class="rev-xref-ref" href="#xref-ref-71-1" title="View reference 71. in text" id="ref-71">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.71" data-doi="10.1128/JVI.01854-10"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sloan</span>,  <span class="cit-name-given-names">R. D.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef</span>. <abbr class="cit-jnl-abbrev">J. Virol.</abbr> <span class="cit-vol">85</span>, <span class="cit-fpage">2828</span>–<span class="cit-lpage">2836</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01854-10%26rft_id%253Dinfo%253Apmid%252F21209113%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6Ijg1LzYvMjgyOCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE4LzA0LzExLzIwMTUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">72.</span><a class="rev-xref-ref" href="#xref-ref-72-1" title="View reference 72. in text" id="ref-72">↵</a><div class="cit ref-cit ref-journal" id="cit-201525v2.72" data-doi="10.1126/science.1061548"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wu</span>,  <span class="cit-name-given-names">Y.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Marsh</span>,  <span class="cit-name-given-names">J. W.</span></span> <span class="cit-article-title">Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA</span>. <abbr class="cit-jnl-abbrev">Science</abbr> <span class="cit-vol">293</span>, <span class="cit-fpage">1503</span>–<span class="cit-lpage">1506</span> (<span class="cit-pub-date">2001</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DScience%26rft.stitle%253DScience%26rft.aulast%253DWu%26rft.auinit1%253DY.%26rft.volume%253D293%26rft.issue%253D5534%26rft.spage%253D1503%26rft.epage%253D1506%26rft.atitle%253DSelective%2BTranscription%2Band%2BModulation%2Bof%2BResting%2BT%2BCell%2BActivity%2Bby%2BPreintegrated%2BHIV%2BDNA%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.1061548%26rft_id%253Dinfo%253Apmid%252F11520990%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEzOiIyOTMvNTUzNC8xNTAzIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTgvMDQvMTEvMjAxNTI1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://www.biorxiv.org/content/10.1101/201525v2.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://biorxivstage.disqus.com/?url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F201525v2" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/220681v2" title="The fractured landscape of RNA-seq alignment: The default in our STARs" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/283929v2-0" title="Cell-type heterogeneity in adipose tissue is associated with complex traits and reveals disease-relevant cell-specific eQTLs" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;April 11, 2018.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/201525v2.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><i class="icon-external-link-sign"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-supplementary-fragment" >
  
      
  
  <div class="pane-content">
    <p><a href="/content/10.1101/201525v2.supplementary-material"><i class="icon-file"></i>Supplementary Material </a></p>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/201525v2.full" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about bioRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/201525v2" class="active" data-icon-position="" data-hide-link-title="0">IFITM proteins inhibit HIV-1 protein synthesis</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from bioRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the bioRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/92005" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-3ugM9IO-U0hovn151nsvE2y1MA6v43SvQkROxlWq0es" />
<input type="hidden" name="form_id" value="forward_form" />
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="92005" id="node92005--2" data-pisa="biorxiv;201525v2" data-pisa-master="biorxiv;201525" data-seqnum="92005" data-apath="/biorxiv/early/2018/04/11/201525.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">IFITM proteins inhibit HIV-1 protein synthesis</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Wing-Yiu Jason</span> <span class="nlm-surname">Lee</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Chen</span> <span class="nlm-surname">Liang</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Richard D</span> <span class="nlm-surname">Sloan</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">201525; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/201525 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.biorxiv.org/content/10.1101/201525v2" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;title=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;title=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;text=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;title=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;t=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;title=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;title=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="92005" id="node92005--3" data-pisa="biorxiv;201525v2" data-pisa-master="biorxiv;201525" data-seqnum="92005" data-apath="/biorxiv/early/2018/04/11/201525.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">IFITM proteins inhibit HIV-1 protein synthesis</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Wing-Yiu Jason</span> <span class="nlm-surname">Lee</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Chen</span> <span class="nlm-surname">Liang</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Richard D</span> <span class="nlm-surname">Sloan</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">201525; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/201525 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis&amp;rft.volume&amp;rft.issue&amp;rft.date=2018-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=bioRxiv&amp;rft.au=Lee%2C+Wing-Yiu+Jason&amp;rft.au=Liang%2C+Chen&amp;rft.au=Sloan%2C+Richard+D"></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/92005/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/92005/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/92005/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/92005/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/92005/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/92005/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/92005/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/92005/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/92005/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/92005/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/92005/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/92005/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;count=horizontal&amp;via=&amp;text=IFITM%20proteins%20inhibit%20HIV-1%20protein%20synthesis&amp;counturl=https%3A//www.biorxiv.org/content/10.1101/201525v2" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.biorxiv.org/content/10.1101/201525v2&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.biorxiv.org/content/10.1101/201525v2" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/microbiology" class="highlight" data-icon-position="" data-hide-link-title="0">Microbiology<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/animal-behavior-and-cognition" class="" data-icon-position="" data-hide-link-title="0">Animal Behavior and Cognition</a> <span class = "article-count">(1789)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biochemistry" class="" data-icon-position="" data-hide-link-title="0">Biochemistry</a> <span class = "article-count">(3141)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioengineering" class="" data-icon-position="" data-hide-link-title="0">Bioengineering</a> <span class = "article-count">(2136)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioinformatics" class="" data-icon-position="" data-hide-link-title="0">Bioinformatics</a> <span class = "article-count">(11098)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biophysics" class="" data-icon-position="" data-hide-link-title="0">Biophysics</a> <span class = "article-count">(4575)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cancer-biology" class="" data-icon-position="" data-hide-link-title="0">Cancer Biology</a> <span class = "article-count">(3584)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cell-biology" class="" data-icon-position="" data-hide-link-title="0">Cell Biology</a> <span class = "article-count">(5072)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/clinical-trials" class="" data-icon-position="" data-hide-link-title="0">Clinical Trials</a> <span class = "article-count">(137)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/developmental-biology" class="" data-icon-position="" data-hide-link-title="0">Developmental Biology</a> <span class = "article-count">(3114)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ecology" class="" data-icon-position="" data-hide-link-title="0">Ecology</a> <span class = "article-count">(4915)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(2044)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/evolutionary-biology" class="" data-icon-position="" data-hide-link-title="0">Evolutionary Biology</a> <span class = "article-count">(7708)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetics" class="" data-icon-position="" data-hide-link-title="0">Genetics</a> <span class = "article-count">(5844)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genomics" class="" data-icon-position="" data-hide-link-title="0">Genomics</a> <span class = "article-count">(7321)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/immunology" class="" data-icon-position="" data-hide-link-title="0">Immunology</a> <span class = "article-count">(2735)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/microbiology" class="" data-icon-position="" data-hide-link-title="0">Microbiology</a> <span class = "article-count">(8398)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/molecular-biology" class="" data-icon-position="" data-hide-link-title="0">Molecular Biology</a> <span class = "article-count">(3345)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neuroscience" class="" data-icon-position="" data-hide-link-title="0">Neuroscience</a> <span class = "article-count">(20277)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/paleontology" class="" data-icon-position="" data-hide-link-title="0">Paleontology</a> <span class = "article-count">(147)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(529)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-toxicology" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Toxicology</a> <span class = "article-count">(867)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/physiology" class="" data-icon-position="" data-hide-link-title="0">Physiology</a> <span class = "article-count">(1311)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/plant-biology" class="" data-icon-position="" data-hide-link-title="0">Plant Biology</a> <span class = "article-count">(3026)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/scientific-communication-and-education" class="" data-icon-position="" data-hide-link-title="0">Scientific Communication and Education</a> <span class = "article-count">(736)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/synthetic-biology" class="" data-icon-position="" data-hide-link-title="0">Synthetic Biology</a> <span class = "article-count">(976)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/systems-biology" class="" data-icon-position="" data-hide-link-title="0">Systems Biology</a> <span class = "article-count">(3039)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/zoology" class="" data-icon-position="" data-hide-link-title="0">Zoology</a> <span class = "article-count">(503)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js" defer="defer"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__llgGUcz2-k3Jmyyyog-_4yI1wJfGWwx0eQ2lbnM9IIo__t6UjIjIKIAD6nKc6BAU9qmlVV2VR4CBTNQbxlbJPgN0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" src="//d33xdlntwy0kbs.cloudfront.net/cshl_custom.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
  </body>
</html>
